{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 14134, "items": [{"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:50:59Z", "timestamp": 1574729459433}, "reference-count": 62, "publisher": "Future Science Ltd", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmaceutical Patent Analyst"], "published-print": {"date-parts": [[2015, 9]]}, "DOI": "10.4155/ppa.15.20", "type": "journal-article", "created": {"date-parts": [[2015, 9, 21]], "date-time": "2015-09-21T18:24:35Z", "timestamp": 1442859875000}, "page": "387-402", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer"], "prefix": "10.4155", "volume": "4", "author": [{"given": "Guillermo", "family": "Martinez-Ariza", "sequence": "first", "affiliation": []}, {"given": "Christopher", "family": "Hulme", "sequence": "additional", "affiliation": []}], "member": "2641", "reference": [{"key": "B1", "DOI": "10.3322/caac.21254", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1210/er.2002-0032", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1074/jbc.M113.534859", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1158/1078-0432.CCR-1146-03", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1038/35094009", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.3390/ijms140612496", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1016/j.ccr.2010.05.026", "doi-asserted-by": "publisher"}, {"key": "B8", "author": "Lonergan PE", "volume": "16", "first-page": "351", "year": "2013", "journal-title": "Protein Rev."}, {"key": "B9", "DOI": "10.1038/ng0495-401", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1038/onc.2014.115", "doi-asserted-by": "publisher"}, {"issue": "11", "key": "B18", "first-page": "2861", "volume": "54", "author": "Gaddipati JPJ", "year": "1994", "journal-title": "Cancer Res."}, {"key": "B19", "DOI": "10.1002/med.21275", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1073/pnas.0500381102", "doi-asserted-by": "publisher"}, {"key": "B23", "DOI": "10.1158/2159-8290.CD-13-0142", "doi-asserted-by": "publisher"}, {"key": "B24", "DOI": "10.1158/2159-8290.CD-13-0226", "doi-asserted-by": "publisher"}, {"key": "B25", "DOI": "10.1158/0008-5472.CAN-11-3948", "doi-asserted-by": "publisher"}, {"key": "B26", "DOI": "10.7554/eLife.00499", "doi-asserted-by": "publisher"}, {"key": "B27", "author": "Jospeh JD", "year": "2012", "volume-title": "The AACR Special Conferences on Advances in Prostate Cancer Research"}, {"key": "B28", "DOI": "10.1200/JCO.2013.50.1684", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1016/S0140-6736(10)61389-X", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1056/NEJMoa1014618", "doi-asserted-by": "publisher"}, {"issue": "13", "key": "B33", "first-page": "213", "volume": "367", "author": "Parker C", "year": "2012", "journal-title": "N. Eng. J. Med."}, {"key": "B34", "DOI": "10.1056/NEJMoa1001294", "doi-asserted-by": "publisher"}, {"key": "B36", "DOI": "10.1073/pnas.1012443107", "doi-asserted-by": "publisher"}, {"key": "B37", "DOI": "10.1111/bju.12415", "doi-asserted-by": "publisher"}, {"key": "B38", "DOI": "10.1111/j.1742-1241.2011.02799.x", "doi-asserted-by": "publisher"}, {"key": "B39", "DOI": "10.1074/jbc.M112.428409", "doi-asserted-by": "publisher"}, {"key": "B40", "DOI": "10.1007/s12672-014-0177-y", "doi-asserted-by": "publisher"}, {"key": "B41", "DOI": "10.1016/j.cell.2013.11.012", "doi-asserted-by": "publisher"}, {"key": "B42", "DOI": "10.1038/nrc2795", "doi-asserted-by": "publisher"}, {"key": "B43", "author": "Ishizaki F", "volume": "3", "first-page": "1528", "year": "2013", "journal-title": "Sci. Rep.", "DOI": "10.1038/srep01528", "doi-asserted-by": "crossref"}, {"key": "B44", "DOI": "10.1210/me.2005-0231", "doi-asserted-by": "publisher"}, {"key": "B45", "DOI": "10.1126/scitranslmed.3005688", "doi-asserted-by": "publisher"}, {"key": "B46", "DOI": "10.1021/bi702221e", "doi-asserted-by": "publisher"}, {"key": "B47", "DOI": "10.1158/0008-5472.CAN_10-3398", "doi-asserted-by": "publisher"}, {"key": "B51", "DOI": "10.1021/ol802021w", "doi-asserted-by": "publisher"}, {"key": "B54", "DOI": "10.1021/jm2014056", "doi-asserted-by": "publisher"}, {"key": "B55", "DOI": "10.1371/journal.pone.0107991", "doi-asserted-by": "publisher"}, {"key": "B58", "DOI": "10.1016/j.ccr.2010.04.027", "doi-asserted-by": "publisher"}, {"key": "B59", "DOI": "10.1172/JCI66398", "doi-asserted-by": "publisher"}, {"key": "B64", "DOI": "10.18632/oncotarget.2924", "doi-asserted-by": "publisher"}, {"key": "B65", "DOI": "10.1016/j.molonc.2014.10.014", "doi-asserted-by": "publisher"}, {"key": "B66", "DOI": "10.1016/bs.acr.2015.03.001", "doi-asserted-by": "publisher"}, {"key": "B67", "DOI": "10.1073/pnas.0401123101", "doi-asserted-by": "publisher"}, {"key": "B68", "DOI": "10.1073/pnas.1222035110", "doi-asserted-by": "publisher"}, {"key": "B74", "DOI": "10.1021/cb400759d", "doi-asserted-by": "publisher"}, {"key": "B75", "DOI": "10.1021/jm500802j", "doi-asserted-by": "publisher"}, {"key": "B78", "DOI": "10.1074/jbc.M114.553818", "doi-asserted-by": "publisher"}, {"key": "B79", "DOI": "10.1073/pnas.0708036104", "doi-asserted-by": "publisher"}, {"key": "B80", "DOI": "10.1016/j.mce.2011.08.012", "doi-asserted-by": "publisher"}, {"key": "B81", "DOI": "10.1021/cb900043e", "doi-asserted-by": "publisher"}, {"key": "B82", "DOI": "10.1021/jm200532b", "doi-asserted-by": "publisher"}, {"key": "B84", "DOI": "10.1021/jm201438f", "doi-asserted-by": "publisher"}, {"key": "B87", "DOI": "10.1073/pnas.1105160108", "doi-asserted-by": "publisher"}, {"key": "B90", "DOI": "10.1021/jm201098n", "doi-asserted-by": "publisher"}, {"key": "B91", "DOI": "10.1021/jm3015712", "doi-asserted-by": "publisher"}, {"key": "B92", "DOI": "10.1021/jm500684r", "doi-asserted-by": "publisher"}, {"key": "B93", "DOI": "10.1016/j.chembiol.2014.09.012", "doi-asserted-by": "publisher"}, {"key": "B95", "DOI": "10.1016/j.bmcl.2013.10.003", "doi-asserted-by": "publisher"}, {"key": "B96", "DOI": "10.1017/erm.2012.10", "doi-asserted-by": "publisher"}, {"key": "B97", "DOI": "10.1021/jm501092z", "doi-asserted-by": "publisher"}, {"key": "B98", "DOI": "10.1073/pnas.0807282106", "doi-asserted-by": "publisher"}], "container-title": ["Pharmaceutical Patent Analyst"], "language": "en", "link": [{"URL": "http://www.future-science.com/doi/pdf/10.4155/ppa.15.20", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:49:17Z", "timestamp": 1574243357000}, "score": 95.87274, "issued": {"date-parts": [[2015, 9]]}, "references-count": 62, "journal-issue": {"published-print": {"date-parts": [[2015, 9]]}, "issue": "5"}, "alternative-id": ["10.4155/ppa.15.20"], "URL": "http://dx.doi.org/10.4155/ppa.15.20", "relation": {"cites": []}, "ISSN": ["2046-8954"], "issn-type": [{"value": "2046-8954", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T02:28:49Z", "timestamp": 1575512929180}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 9, 1]], "date-time": "2019-09-01T00:00:00Z", "timestamp": 1567296000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["redjournal.org", "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["International Journal of Radiation Oncology*Biology*Physics"], "published-print": {"date-parts": [[2019, 9]]}, "DOI": "10.1016/j.ijrobp.2019.06.1908", "type": "journal-article", "created": {"date-parts": [[2019, 9, 14]], "date-time": "2019-09-14T01:33:23Z", "timestamp": 1568424803000}, "page": "E278-E279", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Influence of Statins on Survival Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Inhibitors"], "prefix": "10.1016", "volume": "105", "author": [{"given": "I. Henriquez", "family": "Lopez", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Gomez", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Torres", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Acosta", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Arquez", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "LaFuerza", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Miranda", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Arenas", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["International Journal of Radiation Oncology*Biology*Physics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0360301619327439?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0360301619327439?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 14]], "date-time": "2019-09-14T01:33:23Z", "timestamp": 1568424803000}, "score": 36.99012, "issued": {"date-parts": [[2019, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 9]]}, "issue": "1"}, "alternative-id": ["S0360301619327439"], "URL": "http://dx.doi.org/10.1016/j.ijrobp.2019.06.1908", "ISSN": ["0360-3016"], "issn-type": [{"value": "0360-3016", "type": "print"}], "subject": ["Cancer Research", "Oncology", "Radiation", "Radiology Nuclear Medicine and imaging"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Influence of Statins on Survival Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Inhibitors", "name": "articletitle", "label": "Article Title"}, {"value": "International Journal of Radiation Oncology*Biology*Physics", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ijrobp.2019.06.1908", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2019 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:56:15Z", "timestamp": 1574726175696}, "publisher-location": "Weinheim, Germany", "reference-count": 28, "publisher": "Wiley-VCH Verlag GmbH & Co. KGaA", "isbn-type": [{"value": "9783527341153", "type": "print"}, {"value": "9783527800315", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9783527800315.ch6", "type": "book-chapter", "created": {"date-parts": [[2016, 12, 14]], "date-time": "2016-12-14T20:19:59Z", "timestamp": 1481746799000}, "page": "115-135", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abiraterone Acetate (Zytiga\u00ae): An Inhibitor of CYP17 as a Therapeutic for Castration-Resistant Prostate Cancer"], "prefix": "10.1002", "author": [{"given": "Gabriel M.", "family": "Belfort", "sequence": "first", "affiliation": []}, {"given": "Boyd L.", "family": "Harrison", "sequence": "additional", "affiliation": []}, {"given": "Gabriel", "family": "Martinez Botella", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 12, 2]]}, "reference": [{"key": "10.1002/9783527800315.ch6-BIB0001|c6-cit-0001", "unstructured": "Ferlay , J. Soerjomataram , I. Ervik , M. Dikshit , R. Eser , S. Mathers , C. Rebelo , M. Parkin , D.M. Forman , D. Bray , F. 2014 GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France International Agency for Research on Cancer http://globocan.iarc.fr"}, {"key": "10.1002/9783527800315.ch6-BIB0002|c6-cit-0002", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.3322/caac.21332", "article-title": "Cancer Statistics, 2016", "volume": "66", "author": "Siegel", "year": "2016", "journal-title": "CA Cancer J Clin."}, {"key": "10.1002/9783527800315.ch6-BIB0003|c6-cit-0003", "doi-asserted-by": "crossref", "first-page": "3867", "DOI": "10.1158/1078-0432.CCR-11-0943", "article-title": "Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients", "volume": "17", "author": "Attard", "year": "2011", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527800315.ch6-BIB0004|c6-cit-0004", "doi-asserted-by": "crossref", "first-page": "1147", "DOI": "10.1016/S0140-6736(10)61389-X", "article-title": "Prednisone plus cabazitaxel or mitoxantrone for metastatic castratio-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial", "volume": "376", "author": "Bono", "year": "2010", "journal-title": "Lancet"}, {"key": "10.1002/9783527800315.ch6-BIB0005|c6-cit-0005", "doi-asserted-by": "crossref", "first-page": "3670", "DOI": "10.1002/cncr.24429", "article-title": "Integrated data from 2 randomised, double blind, placebo controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advance prostate cancer", "volume": "115", "author": "Higano", "year": "2009", "journal-title": "Cancer"}, {"key": "10.1002/9783527800315.ch6-BIB0006|c6-cit-0006", "doi-asserted-by": "crossref", "first-page": "2231", "DOI": "10.1021/jm00130a001", "article-title": "Is there a case for P450 inhibitors for cancer treatment?", "volume": "32", "author": "Van Wauwe", "year": "1989", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9783527800315.ch6-BIB0007|c6-cit-0007", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/0960-0760(95)00230-8", "article-title": "P450-dependent enzymes as target for prostate cancer thereapy", "volume": "56", "author": "De Coster", "year": "1996", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10.1002/9783527800315.ch6-BIB0008|c6-cit-0008", "doi-asserted-by": "crossref", "first-page": "4037", "DOI": "10.1021/bi00517a014", "article-title": "Microsomal Cytochrome P450 from neonatal pig testis: Two enzymatic activities (17\u03b1-hydroxylase and C17,20-lyase) associated with one protein", "volume": "20", "author": "Nakajin", "year": "1981", "journal-title": "Biochemistry"}, {"issue": "8400", "key": "10.1002/9783527800315.ch6-BIB0009|c6-cit-0009", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/S0140-6736(84)92909-X", "article-title": "Ketoconazole theory for advanced prostatic cancer", "volume": "324", "author": "Pont", "year": "1984", "journal-title": "Lancet"}, {"key": "10.1002/9783527800315.ch6-BIB0010|c6-cit-0010", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1038/nrd3516", "article-title": "Abiraterone Acetate", "volume": "10", "author": "Logothetis", "year": "2011", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10.1002/9783527800315.ch6-BIB0011|c6-cit-0011", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.2147/DDDT.S15850", "article-title": "Abiraterone acetate: Oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer", "volume": "6", "author": "Rehman", "year": "2012", "journal-title": "Drug Des. Dev. Ther."}, {"key": "10.1002/9783527800315.ch6-BIB0012|c6-cit-0012", "unstructured": "Zytiga \u00ae (abiraterone acetate) - US Food and Drug Administation (FDA) Label (2012) www.accessdata.fda.gov/drugsatfda_docs/label/2012/202379s005lbl.pdf"}, {"key": "10.1002/9783527800315.ch6-BIB0013|c6-cit-0013", "doi-asserted-by": "crossref", "first-page": "3050", "DOI": "10.1021/jm00173a022", "article-title": "Inhibition of enzymes of estrogen and androgen biosyntheis by esters of 4-pyridylacetic acid", "volume": "33", "author": "Mc Cague", "year": "1990", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9783527800315.ch6-BIB0014|c6-cit-0014", "doi-asserted-by": "crossref", "first-page": "3060", "DOI": "10.1021/jm00173a023", "article-title": "Inhibitors of the P450 enzymes aromatase and lyase. Crystallographic and molecular modelling studies suggest structural features of pyridylacetic acid derivatives responsible for differences in enzyme inhibitory activity", "volume": "33", "author": "Laughton", "year": "1990", "journal-title": "J. Med. Chem"}, {"key": "10.1002/9783527800315.ch6-BIB0015|c6-cit-0015", "doi-asserted-by": "crossref", "first-page": "4191", "DOI": "10.1021/jm00021a008", "article-title": "Esters of 3-pyridylacetic acid that combine potent inhibition of 17\u03b1-hydroxylase/c17,20-lyase (cytochrome P45017\u03b1) with resistance to esterase hydrolysis", "volume": "38", "author": "Rowlands", "year": "1995", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9783527800315.ch6-BIB0016|c6-cit-0016", "doi-asserted-by": "crossref", "first-page": "2463", "DOI": "10.1021/jm00013a022", "article-title": "Novel steroidal inhibitors of human cytochrome P45017\u03b1 (17\u03b1-hydroxylase-c17,20-lyase): Potential agents for the treatment of prostatic cancer", "volume": "38", "author": "Potter", "year": "1995", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9783527800315.ch6-BIB0017|c6-cit-0017", "doi-asserted-by": "crossref", "first-page": "5375", "DOI": "10.1021/jm981017j", "article-title": "The 16,17-double bond is needed for irreversible inhibition of human cytochrome P45017\u03b1 by abiraterone (17-(3-pyridyl)androsta-5,16-dien-3\u03b2-ol) and related steroidal inhibitors", "volume": "41", "author": "Jarman", "year": "1998", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9783527800315.ch6-BIB0018|c6-cit-0018", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1016/S0960-0760(03)00078-5", "article-title": "In vitro and in vivo models for the evaluation of potent inhibitors of male rat 17\u03b1-hydroxylase/C17,20-lyase", "volume": "84", "author": "Duc", "year": "2003", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10.1002/9783527800315.ch6-BIB0019|c6-cit-0019", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1016/S0960-0760(03)00070-0", "article-title": "Effects of novel 17\u03b1-hydroxylase/c17,20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo", "volume": "84", "author": "Haidar", "year": "2003", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10.1002/9783527800315.ch6-BIB0020|c6-cit-0020", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1016/0960-0760(94)90131-7", "article-title": "Pharmacology of novel steroidal inhibitors of cytochrome P45017\u03b1 (17\u03b1-hydroxylase/c17-20 lyase)", "volume": "50", "author": "Barrie", "year": "1994", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10.1002/9783527800315.ch6-BIB0021|c6-cit-0021", "author": "Montgomery", "year": "2009", "volume-title": "Advances in Prostate Cancer Research"}, {"key": "10.1002/9783527800315.ch6-BIB0022|c6-cit-0022", "unstructured": "Zytiga \u00ae (abiraterone):EPAR-Public assessment report (2011) http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002321/WC500112860.pdf"}, {"key": "10.1002/9783527800315.ch6-BIB0023|c6-cit-0023", "doi-asserted-by": "crossref", "first-page": "5009", "DOI": "10.1021/jm800355c", "article-title": "Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: Novel CYP17 inhibitors for the treatment of prostate cancer", "volume": "51", "author": "Pinto-Bazurco Mendieta", "year": "2008", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9783527800315.ch6-BIB0024|c6-cit-0024", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.3322/canjclin.52.3.154", "article-title": "The current state of hormone therapy for prostate cancer", "volume": "52", "author": "Hellerstedt", "year": "2002", "journal-title": "CA Cancer J. Clin."}, {"key": "10.1002/9783527800315.ch6-BIB0025|c6-cit-0025", "doi-asserted-by": "crossref", "first-page": "1502", "DOI": "10.1056/NEJMoa040720", "article-title": "Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer", "volume": "351", "author": "Tannock", "year": "2004", "journal-title": "N. Engl. J. Med."}, {"key": "10.1002/9783527800315.ch6-BIB0026|c6-cit-0026", "doi-asserted-by": "crossref", "first-page": "1995", "DOI": "10.1056/NEJMoa1014618", "article-title": "Abiraterone and increased survival in metastatic prostate cancer", "volume": "364", "author": "Bono", "year": "2011", "journal-title": "N. Engl. J. Med."}, {"key": "10.1002/9783527800315.ch6-BIB0027|c6-cit-0027", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1056/NEJMoa1209096", "article-title": "Abiraterone om metastatic prosate cance without previous chemotherapy", "volume": "368", "author": "Ryan", "year": "2013", "journal-title": "N. Engl. J. Med."}, {"key": "10.1002/9783527800315.ch6-BIB0028|c6-cit-0028", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1634/theoncologist.2013-0092", "article-title": "The european medicines agency review of abiraterone for the treatment of metastatic castration-resistant prostate cancer in adult men after docetaxel chemotherapy and in chemotherapy-na\u00efve disease: Summary of the scientific assessment of the committee for medicinal products for human use", "volume": "18", "author": "Gravanis", "year": "2013", "journal-title": "Oncologyst"}], "container-title": ["Successful Drug Discovery"], "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9783527800315.ch6", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9783527800315.ch6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T23:18:11Z", "timestamp": 1533597491000}, "score": 29.522575, "issued": {"date-parts": [[2016, 12, 2]]}, "ISBN": ["9783527800315", "9783527341153"], "references-count": 28, "URL": "http://dx.doi.org/10.1002/9783527800315.ch6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:49:07Z", "timestamp": 1574484547524}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 9, 15]]}, "DOI": "10.1158/1538-7445.fbcr11-c9", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T14:33:33Z", "timestamp": 1340807613000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract C9: Quantitative modeling of androgen receptor-mediated transcriptional complexes in human prostate cancer cells"], "prefix": "10.1158", "author": [{"given": "Jordy J.", "family": "Hsiao", "sequence": "first", "affiliation": []}, {"given": "Hairyl D.", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "Michael E.", "family": "Wright", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 10, 28]]}, "event": {"name": "Abstracts: Second AACR International Conference on Frontiers in Basic Cancer Research--Sep 14-18, 2011; San Francisco, CA"}, "container-title": ["Emerging Technologies for Cancer Research"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.FBCR11-C9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:33:38Z", "timestamp": 1558215218000}, "score": 29.325005, "issued": {"date-parts": [[2011, 9, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.FBCR11-C9"], "URL": "http://dx.doi.org/10.1158/1538-7445.fbcr11-c9"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T15:40:53Z", "timestamp": 1575474053723}, "reference-count": 20, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2019, 7, 9]], "date-time": "2019-07-09T00:00:00Z", "timestamp": 1562630400000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100004326", "name": "Bayer", "doi-asserted-by": "crossref", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate Cancer"], "published-print": {"date-parts": [[2019, 7, 9]]}, "abstract": "<jats:p><jats:italic>Background and Objective</jats:italic>. Skeletal-related events (SREs) are common in men with bone metastases and have negative consequences for patients with castration-resistant prostate cancer (CRPC), including pain, reduced quality of life, and increased mortality. We estimated incidence rates of first SREs in a cohort of men with CRPC in the Surveillance, Epidemiology, and End Results-Medicare database.<jats:italic> Methods</jats:italic>. We included men aged \u2265 65 years with a prostate cancer diagnosis in 2000-2011 if they had no prior malignancy (other than nonmelanoma skin cancer) and had surgical or medical castration with subsequent second-line systemic therapy, which was used to infer castration resistance. The first occurrence of an SRE (fracture, bone surgery, radiation therapy, or spinal cord compression) in Medicare claims was identified. Incidence rates of SREs were estimated in all eligible person-time and, in secondary analyses, stratified by any use of bone-targeted agents (BTAs) and history of SRE.<jats:italic> Results</jats:italic>. Of 2,234 men with CRPC (84% white, mean age = 76.6 years), 896 (40%) had an SRE during follow-up, with 74% occurring within a year after cohort entry. Overall, the incidence rate of SREs was 3.78 (95% CI, 3.53-4.03) per 100 person-months. The incidence rate of SREs before any BTA use was 4.16 (95% CI, 3.71-4.65) per 100 person-months, and after any BTA use was 3.60 (95% CI, 3.32-3.91) per 100 person-months. The incidence rate in patients with no history of SRE was 3.33 (95% CI 3.01-3.68) per 100 person-months, and in patients who had such a history, it was 4.20 (95% CI 3.84-4.58) per 100 person-months.<jats:italic> Conclusions</jats:italic>. In this large cohort of elderly men with CRPC in the US, SREs were common. A decrease in incidence of SREs after starting BTA is suggested, but the magnitude of the effect may be confounded by indication and other factors such as age and prior SRE.</jats:p>", "DOI": "10.1155/2019/5971615", "type": "journal-article", "created": {"date-parts": [[2019, 7, 9]], "date-time": "2019-07-09T23:31:01Z", "timestamp": 1562715061000}, "page": "1-7", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US"], "prefix": "10.1155", "volume": "2019", "author": [{"ORCID": "http://orcid.org/0000-0002-2923-2169", "authenticated-orcid": true, "given": "Alison Tse", "family": "Kawai", "sequence": "first", "affiliation": [{"name": "RTI Health Solutions, Waltham, Massachusetts, USA"}]}, {"given": "David", "family": "Martinez", "sequence": "additional", "affiliation": [{"name": "RTI Health Solutions, Barcelona, Spain"}]}, {"ORCID": "http://orcid.org/0000-0003-4727-5987", "authenticated-orcid": true, "given": "Catherine W.", "family": "Saltus", "sequence": "additional", "affiliation": [{"name": "RTI Health Solutions, Waltham, Massachusetts, USA"}]}, {"given": "Zdravko P.", "family": "Vassilev", "sequence": "additional", "affiliation": [{"name": "Bayer US, Whippany, New Jersey, USA"}]}, {"given": "Montse", "family": "Soriano-Gabarr\u00f3", "sequence": "additional", "affiliation": [{"name": "Bayer AG, Berlin, Germany"}]}, {"ORCID": "http://orcid.org/0000-0002-9357-4227", "authenticated-orcid": true, "given": "James A.", "family": "Kaye", "sequence": "additional", "affiliation": [{"name": "RTI Health Solutions, Waltham, Massachusetts, USA"}]}], "member": "98", "reference": [{"key": "1", "DOI": "10.1634/theoncologist.2015-0327", "doi-asserted-by": "publisher"}, {"key": "2", "DOI": "10.1038/pcan.2016.62", "doi-asserted-by": "publisher"}, {"key": "3", "DOI": "10.5489/cuaj.5053", "doi-asserted-by": "publisher"}, {"key": "4", "DOI": "10.1002/cncr.30505", "doi-asserted-by": "publisher"}, {"key": "5", "DOI": "10.1016/j.juro.2010.03.034", "doi-asserted-by": "publisher"}, {"key": "6", "year": "2018"}, {"key": "7", "volume": "26", "first-page": "294", "year": "2017", "journal-title": "Pharmacoepidemiology and Drug Safety", "DOI": "10.1002/pds.4079", "doi-asserted-by": "crossref"}, {"key": "8", "DOI": "10.1155/2019/4387415", "doi-asserted-by": "publisher"}, {"key": "9", "DOI": "10.1038/pcan.2012.42", "doi-asserted-by": "publisher"}, {"key": "10", "volume": "25", "issue": "s334", "year": "2016", "journal-title": "Pharmacoepidemiology and Drug Safety"}, {"key": "11", "DOI": "10.1053/hp.2000.6698", "doi-asserted-by": "publisher"}, {"key": "12", "year": "2015"}, {"key": "13", "DOI": "10.1007/s11934-017-0724-5", "doi-asserted-by": "publisher"}, {"key": "14", "DOI": "10.3322/caac.21555", "doi-asserted-by": "publisher"}, {"key": "15", "DOI": "10.3322/caac.21494", "doi-asserted-by": "publisher"}, {"key": "16", "DOI": "10.3322/caac.21551", "doi-asserted-by": "publisher"}, {"key": "17", "DOI": "10.1038/ki.2013.443", "doi-asserted-by": "publisher"}, {"key": "18", "DOI": "10.1093/ajcn/88.2.545S", "doi-asserted-by": "publisher"}, {"key": "19", "DOI": "10.1002/cam4.914", "doi-asserted-by": "publisher"}, {"key": "20", "year": "2019"}], "container-title": ["Prostate Cancer"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/pc/2019/5971615.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/pc/2019/5971615.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/pc/2019/5971615.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 9]], "date-time": "2019-07-09T23:31:03Z", "timestamp": 1562715063000}, "score": 28.843052, "issued": {"date-parts": [[2019, 7, 9]]}, "references-count": 20, "alternative-id": ["5971615", "5971615"], "URL": "http://dx.doi.org/10.1155/2019/5971615", "relation": {"cites": []}, "ISSN": ["2090-3111", "2090-312X"], "issn-type": [{"value": "2090-3111", "type": "print"}, {"value": "2090-312X", "type": "electronic"}], "subject": ["Urology", "Cancer Research", "Oncology"]}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:58:07Z", "timestamp": 1574816287733}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005, 2, 1]]}, "DOI": "10.21236/ada442814", "type": "report", "created": {"date-parts": [[2017, 7, 28]], "date-time": "2017-07-28T13:06:14Z", "timestamp": 1501247174000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Characterization of a Novel Intracellular Receptor for Phorbol Esters and Diacylglycerol in Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Jose L.", "family": "Martinez", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 28]], "date-time": "2017-07-28T13:06:14Z", "timestamp": 1501247174000}, "score": 27.102543, "subtitle": [""], "issued": {"date-parts": [[2005, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada442814"}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T02:37:32Z", "timestamp": 1576809452337}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2016, 5, 20]]}, "DOI": "10.1200/jco.2016.34.15_suppl.tps5091", "type": "journal-article", "created": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:30:07Z", "timestamp": 1536251407000}, "page": "TPS5091-TPS5091", "source": "Crossref", "is-referenced-by-count": 1, "title": ["A phase I/II trial of enzalutamide plus the glucocorticoid receptor antagonist mifepristone for patients with metastatic castration-resistant prostate cancer (mCRPC)."], "prefix": "10.1200", "volume": "34", "author": [{"given": "Russell Zelig", "family": "Szmulewitz", "sequence": "first", "affiliation": [{"name": "The University of Chicago, Chicago, IL;"}]}, {"given": "Chadi", "family": "Nabhan", "sequence": "additional", "affiliation": [{"name": "University of Chicago, Chicago, IL;"}]}, {"given": "Peter H.", "family": "O'Donnell", "sequence": "additional", "affiliation": [{"name": "University of Chicago Comprehensive Cancer Center, Chicago, IL;"}]}, {"given": "Jacob", "family": "Kach", "sequence": "additional", "affiliation": [{"name": "University of Chicago, Chicago, IL;"}]}, {"given": "Theodore", "family": "Karrison", "sequence": "additional", "affiliation": [{"name": "The University of Chicago, Chicago, IL;"}]}, {"given": "Elia", "family": "Martinez", "sequence": "additional", "affiliation": [{"name": "The University of Chicago, Chicago, IL;"}]}, {"given": "Walter Michael", "family": "Stadler", "sequence": "additional", "affiliation": [{"name": "The University of Chicago, Chicago, IL;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.TPS5091", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:43:29Z", "timestamp": 1574891009000}, "score": 26.543736, "issued": {"date-parts": [[2016, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/JCO.2016.34.15_suppl.TPS5091"], "URL": "http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps5091", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T08:56:22Z", "timestamp": 1574758582228}, "reference-count": 83, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 19]], "date-time": "2016-01-19T00:00:00Z", "timestamp": 1453161600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["J Endocrinol Invest"], "published-print": {"date-parts": [[2016, 7]]}, "DOI": "10.1007/s40618-016-0430-z", "type": "journal-article", "created": {"date-parts": [[2016, 1, 19]], "date-time": "2016-01-19T17:10:39Z", "timestamp": 1453223439000}, "page": "729-738", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients"], "prefix": "10.1007", "volume": "39", "author": [{"given": "S.", "family": "Sideris", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Aoun", "sequence": "additional", "affiliation": []}, {"given": "C. N.", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Latifyan", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Awada", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Costante", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Gil", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 1, 19]]}, "reference": [{"key": "430_CR1", "unstructured": "Cancer Research (2015) http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/mortality . Accessed Aug 2015"}, {"key": "430_CR2", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1023/A:1015531326689", "volume": "20", "author": "G Buchanan", "year": "2001", "unstructured": "Buchanan G, Irvine RA, Coetzee GA, Tilley WD (2001) Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 20:207\u2013223", "journal-title": "Cancer Metastasis Rev"}, {"key": "430_CR3", "unstructured": "Oh WK, Hurwitz M, D\u2019Amico AV, Richie JP, Kantoff PW (2003) Biology of prostate cancer. Holland-Frei Cancer Medicine, 6th edn. BC Decker, Hamilton, ON"}, {"key": "430_CR4", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1007/s12672-014-0173-2", "volume": "5", "author": "M Isikbay", "year": "2014", "unstructured": "Isikbay M, Otto K, Kregel S et al (2014) Glucocorticoid receptor activity contributes to resistance to androgen targeted therapy in prostate cancer. Horm Cancer 5:72\u201389", "journal-title": "Horm Cancer"}, {"issue": "1", "key": "430_CR5", "first-page": "S3", "volume": "9", "author": "MA Perlmutter", "year": "2007", "unstructured": "Perlmutter MA, Lepor H (2007) Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol 9(1):S3\u2013S8", "journal-title": "Rev Urol"}, {"issue": "254", "key": "430_CR6", "doi-asserted-by": "publisher", "first-page": "254ra125", "DOI": "10.1126/scitranslmed.3009448", "volume": "6", "author": "S Carreira", "year": "2014", "unstructured": "Carreira S, Romanel A, Goodall J et al (2014) Tumor clone dynamics in lethal prostate cancer. Sci Trans Med 6(254):254ra125. doi: 10.1126/scitranslmed.3009448", "journal-title": "Sci Trans Med"}, {"key": "430_CR7", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1677/ERC-08-0084", "volume": "15", "author": "ML Zhu", "year": "2008", "unstructured": "Zhu ML, Kyprianou N (2008) Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. Endocr Relat Cancer 15:841\u2013849", "journal-title": "Endocr Relat Cancer"}, {"issue": "17", "key": "430_CR8", "doi-asserted-by": "crossref", "first-page": "7217", "DOI": "10.18632/oncotarget.2406", "volume": "5", "author": "E Shtivelman", "year": "2014", "unstructured": "Shtivelman E, Beer TM, Evans CP (2014) Molecular pathways and targets in prostate cancer. Oncotarget 5(17):7217\u20137259", "journal-title": "Oncotarget"}, {"issue": "18", "key": "430_CR9", "doi-asserted-by": "crossref", "first-page": "1697", "DOI": "10.1056/NEJMoa1506859", "volume": "373", "author": "J Mateo", "year": "2015", "unstructured": "Mateo J et al (2015) DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med 373(18):1697\u20131708", "journal-title": "N Engl J Med"}, {"issue": "5", "key": "430_CR10", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1016/j.cell.2015.05.001", "volume": "161", "author": "D Robinson", "year": "2015", "unstructured": "Robinson D et al (2015) Integrative clinical genomics of advanced prostate cancer. Cell 161(5):1215\u20131228", "journal-title": "Cell"}, {"key": "430_CR11", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1038/sj.bjc.6601127", "volume": "89", "author": "J Edwards", "year": "2003", "unstructured": "Edwards J, Krishna NS, Grigor KM, Bartlett JM (2003) Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer 89:552\u2013556", "journal-title": "Br J Cancer"}, {"key": "430_CR12", "doi-asserted-by": "publisher", "first-page": "1028", "DOI": "10.1056/NEJMoa1315815", "volume": "371", "author": "E Antonarakis", "year": "2014", "unstructured": "Antonarakis E et al (2014) AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 371:1028\u20131038. doi: 10.1056/NEJMoa1315815", "journal-title": "N Engl J Med"}, {"key": "430_CR13", "doi-asserted-by": "crossref", "first-page": "4434", "DOI": "10.1158/0008-5472.CAN-08-3605", "volume": "69", "author": "MP Steinkamp", "year": "2009", "unstructured": "Steinkamp MP, O\u2019Mahony OA, Brogley M, Rehman H, Lapensee EW, Dhanasekaran S et al (2009) Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy. Cancer Res 69:4434\u20134442", "journal-title": "Cancer Res"}, {"key": "430_CR14", "doi-asserted-by": "crossref", "first-page": "6407", "DOI": "10.1158/0008-5472.CAN-07-5997", "volume": "68", "author": "JA Locke", "year": "2008", "unstructured": "Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA et al (2008) Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res 68:6407\u20136415", "journal-title": "Cancer Res"}, {"key": "430_CR15", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1210/er.2007-0019", "volume": "28", "author": "HV Heemers", "year": "2007", "unstructured": "Heemers HV, Tindall DJ (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28:778\u2013808", "journal-title": "Endocr Rev"}, {"issue": "1\u20132", "key": "430_CR16", "first-page": "1", "volume": "51", "author": "BR Westley", "year": "1994", "unstructured": "Westley BR, May FEB (1994) Role of Insulin-like growth factors in steroid modulated proliferation. Mol Biol 51(1\u20132):1\u20139", "journal-title": "Mol Biol"}, {"issue": "3", "key": "430_CR17", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1111/j.1365-2613.2012.00817.x", "volume": "93", "author": "M Costa", "year": "2012", "unstructured": "Costa M, Violato N, Taboga S et al (2012) Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats. Int J Exp Pathol 93(3):188\u2013195. doi: 10.1111/j.1365-2613.2012.00817.x", "journal-title": "Int J Exp Pathol"}, {"key": "430_CR18", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1172/JCI119204", "volume": "99", "author": "M Nevalainen", "year": "1997", "unstructured": "Nevalainen M, Valve EM, Ingleton PM et al (1997) Prolactin and prolactin receptors are expressed and functioning in the human prostate. J Clin Invest 99:618\u2013627", "journal-title": "J Clin Invest"}, {"key": "430_CR19", "doi-asserted-by": "crossref", "first-page": "4410", "DOI": "10.1210/endo.138.10.5461", "volume": "138", "author": "H Wennbo", "year": "1997", "unstructured": "Wennbo H, Kindblom J, Isaksson OGP, Tornell J (1997) Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138:4410\u20134415", "journal-title": "Endocrinology"}, {"key": "430_CR20", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/0303-7207(92)90011-T", "volume": "88", "author": "E Reiter", "year": "1992", "unstructured": "Reiter E, Bonnet P, Sente B, Dombrowicz D, de Leval J, Closset J, Hennen G (1992) Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-1 (IGF-1) and IGF-1 receptor levels in the prostate of immature rats. Mol Cell Endocrinol 88:77\u201387", "journal-title": "Mol Cell Endocrinol"}, {"issue": "3", "key": "430_CR21", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1016/S0002-9440(10)65333-3", "volume": "154", "author": "I Leav", "year": "1999", "unstructured": "Leav I, Merk F, Lee KF et al (1999) Prolactin receptor expression in developing human prostateand in hyperplastic, dysplastic and neoplastic lesions. Am J Pathol 154(3):863\u2013870", "journal-title": "Am J Pathol"}, {"issue": "3", "key": "430_CR22", "doi-asserted-by": "publisher", "first-page": "378", "DOI": "10.4103/1008-682X.122876", "volume": "16", "author": "MP Edlind", "year": "2014", "unstructured": "Edlind MP, Hsieh AC (2014) PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance. Asian J Androl 16(3):378\u2013386. doi: 10.4103/1008-682X.122876", "journal-title": "Asian J Androl"}, {"issue": "5", "key": "430_CR23", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1016/j.ccr.2010.03.018", "volume": "17", "author": "J Yu", "year": "2010", "unstructured": "Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17(5):443\u2013454. doi: 10.1016/j.ccr.2010.03.018", "journal-title": "Cancer Cell"}, {"key": "430_CR24", "first-page": "6111", "volume": "60", "author": "Bowen", "year": "2000", "unstructured": "Bowen et al (2000) Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 60:6111\u20136115", "journal-title": "Cancer Res"}, {"key": "430_CR25", "first-page": "699", "volume": "36", "author": "N Tilborgh Van", "year": "2013", "unstructured": "Van Tilborgh N et al (2013) The transcription intermediary factor 1beta co activates the androgen receptor. J Endocrinol Invest 36:699\u2013706", "journal-title": "J Endocrinol Invest"}, {"issue": "1", "key": "430_CR26", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1093/carcin/bgp220", "volume": "31", "author": "S Sharma", "year": "2010", "unstructured": "Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31(1):27\u201336", "journal-title": "Carcinogenesis"}, {"issue": "12", "key": "430_CR27", "doi-asserted-by": "crossref", "first-page": "4550", "DOI": "10.1210/en.2011-1056", "volume": "152", "author": "GL Gravina", "year": "2011", "unstructured": "Gravina GL, Marampon F, Piccolella M, Motta M, Ventura L, Pomante R, Popov VM, Zani BM, Pestell RG, Tombolini V, Jannini EA, Festuccia C (2011) Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. Endocrinology 152(12):4550\u20134561", "journal-title": "Endocrinology"}, {"key": "430_CR28", "first-page": "12454", "volume": "260", "author": "RG Smith", "year": "1985", "unstructured": "Smith RG, Syms AJ, Nag A, Lerner S, Norris JS (1985) Mechanism of the glucocorticoid regulation of growth of the androgen-sensitive prostate-derived R3327H-G8-A1 tumor cell line. J Biol Chem 260:12454\u201312463", "journal-title": "J Biol Chem"}, {"key": "430_CR29", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1038/nrc2090", "volume": "7", "author": "A Marzo De", "year": "2007", "unstructured": "De Marzo A, Platz EA, Sutcliffe S et al (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7:256\u2013259", "journal-title": "Nat Rev Cancer"}, {"issue": "6", "key": "430_CR30", "doi-asserted-by": "publisher", "first-page": "1309", "DOI": "10.1016/j.cell.2013.11.012", "volume": "155", "author": "VK Arora", "year": "2013", "unstructured": "Arora VK, Schenkein E, Murali R et al (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155(6):1309\u20131322. doi: 10.1016/j.cell.2013.11.012", "journal-title": "Cell"}, {"issue": "13", "key": "430_CR31", "doi-asserted-by": "crossref", "first-page": "3353", "DOI": "10.1158/1078-0432.CCR-12-0931", "volume": "19", "author": "R Ferraldeschi", "year": "2013", "unstructured": "Ferraldeschi R, Sharifi N, Auchus RJ, Attard G (2013) Molecular pathways: inhibiting steroid biosynthesis in prostate cancer. Clin Cancer Res 19(13):3353\u20133359", "journal-title": "Clin Cancer Res"}, {"issue": "9", "key": "430_CR32", "doi-asserted-by": "crossref", "first-page": "2176", "DOI": "10.1158/0008-5472.CAN-11-3980", "volume": "72", "author": "J Richards", "year": "2012", "unstructured": "Richards J, Lim AC, Hay CW et al (2012) Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res 72(9):2176\u20132182", "journal-title": "Cancer Res"}, {"key": "430_CR33", "unstructured": "NCIN (2009) Cancer e-Atlas. European age-standardised mortality rates, UK (England: former Primary Care Trusts; Wales; Scotland: NHS Health Boards; Northern Ireland: Health and Social Care Trusts), 2009\u20132011"}, {"key": "430_CR34", "doi-asserted-by": "crossref", "first-page": "1502", "DOI": "10.1056/NEJMoa040720", "volume": "351", "author": "IF Tannock", "year": "2004", "unstructured": "Tannock IF, de Wit R, Berry WR, TAX 327 Investigators et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502\u20131512", "journal-title": "N Engl J Med"}, {"key": "430_CR35", "doi-asserted-by": "crossref", "first-page": "1756", "DOI": "10.1200/JCO.1996.14.6.1756", "volume": "14", "author": "IF Tannock", "year": "1996", "unstructured": "Tannock IF, Osoba D, Stockler MR et al (1996) Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 14:1756\u20131764", "journal-title": "J Clin Oncol"}, {"key": "430_CR36", "doi-asserted-by": "crossref", "first-page": "1147", "DOI": "10.1016/S0140-6736(10)61389-X", "volume": "376", "author": "JS Bono de", "year": "2010", "unstructured": "de Bono JS, Oudard S, Ozguroglu M, TROPIC Investigators et al (2010) Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistantprostate cancer progressing after docetaxel treatment: a randomised open-labeltrial. Lancet 376:1147\u20131154", "journal-title": "Lancet"}, {"key": "430_CR37", "doi-asserted-by": "crossref", "first-page": "1995", "DOI": "10.1056/NEJMoa1014618", "volume": "364", "author": "JS Bono de", "year": "2011", "unstructured": "de Bono JS, Logothetis CJ, Molina A, COU-AA-301 Investigators et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995\u20132005", "journal-title": "N Engl J Med"}, {"key": "430_CR38", "unstructured": "Montgomery RB, Kheoh TS, Molina A et al (2013) Effect of corticosteroid (CS) use at baseline (CUB) on overall survival (OS) in patients receiving abiraterone acetate (AA): results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel (D). In: Presented at ASCO Annual Meeting, Chicago, USA, 31 May\u20134 June 2013"}, {"issue": "2", "key": "430_CR39", "doi-asserted-by": "publisher", "first-page": "138", "DOI": "10.1056/NEJMoa1209096", "volume": "368", "author": "CJ Ryan", "year": "2013", "unstructured": "Ryan CJ, Smith MR, de Bono JS, Molina A, COU-AA-302 Investigators et al (2013) Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 368(2):138\u2013148. doi: 10.1056/NEJMoa1209096 (Epub 2012 Dec 10. Erratum in: N Engl J Med. 2013 Feb 7;368(6):584)", "journal-title": "N Engl J Med"}, {"issue": "13", "key": "430_CR40", "doi-asserted-by": "crossref", "first-page": "1187", "DOI": "10.1056/NEJMoa1207506", "volume": "367", "author": "HI Scher", "year": "2012", "unstructured": "Scher HI, Fizazi K, Saad F et al (2012) AFFIRM Investigators. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367(13):1187\u20131197", "journal-title": "N Engl J Med"}, {"key": "430_CR41", "unstructured": "Scher H I, Fizazi K, Saad F et al. (2013) Impact of on-study corticosteroid use on efficacy and safety in the Phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor. In: Presented at American Society Clinical Oncology (ASCO), Genitourinary Cancers Symposium, Orlando, USA, 14\u201316 February 2013", "DOI": "10.1200/jco.2013.31.6_suppl.6", "doi-asserted-by": "crossref"}, {"key": "430_CR42", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.1056/NEJMoa1405095", "volume": "371", "author": "T Beer", "year": "2014", "unstructured": "Beer T, Armstrong A, Rathkopf D et al (2014) Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med 371:424\u2013433. doi: 10.1056/NEJMoa1405095", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "430_CR43", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1056/NEJMoa1213755", "volume": "369", "author": "C Parker", "year": "2013", "unstructured": "Parker C, Nilsson S, Heinrich D et al (2013) Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 369(3):213\u2013223", "journal-title": "N Engl J Med"}, {"key": "430_CR44", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1056/NEJMoa1001294", "volume": "363", "author": "PW Kantoff", "year": "2010", "unstructured": "Kantoff PW, Higano CS, Shore ND, IMPACT Study Investigators et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl JMed 363:411\u2013422", "journal-title": "N Engl JMed"}, {"key": "430_CR45", "doi-asserted-by": "crossref", "first-page": "1025", "DOI": "10.1200/JCO.2004.06.037", "volume": "22", "author": "EJ Small", "year": "2004", "unstructured": "Small EJ, Halabi S, Dawson NA et al (2004) Antiandrogen withdrawal alone or in combination with ketoconazolein androgen-independent prostate cancer patients: a phase III trial (CALGB 9583). J Clin Oncol 22:1025\u20131033", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "430_CR46", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.3892/ol_00000013", "volume": "1", "author": "A Komiya", "year": "2010", "unstructured": "Komiya A, Shimbo M, Suzuki H et al (2010) Oral low-dose dexamethasone for androgen-independent prostate cancer patients. Oncol Lett 1(1):73\u201379", "journal-title": "Oncol Lett"}, {"key": "430_CR47", "doi-asserted-by": "crossref", "first-page": "1711", "DOI": "10.1056/NEJMra050541", "volume": "353", "author": "T Rhen", "year": "2005", "unstructured": "Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N Engl J Med 353:1711\u20131723", "journal-title": "N Engl J Med"}, {"key": "430_CR48", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1634/theoncologist.9-5-571", "volume": "9", "author": "D Lussier", "year": "2004", "unstructured": "Lussier D, Huskey AG, Portenoy RK (2004) Adjuvant analgesics in cancer pain management. Oncologist 9:571\u2013591", "journal-title": "Oncologist"}, {"issue": "9", "key": "430_CR49", "doi-asserted-by": "crossref", "first-page": "3149", "DOI": "10.1200/JCO.1997.15.9.3149", "volume": "15", "author": "MJ Piccart", "year": "1997", "unstructured": "Piccart MJ, Klijn J, Paridaens R et al (1997) CA significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for breast cancer. J Clin Oncol 15(9):3149\u20133155", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "430_CR50", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1210/jc.2011-2189", "volume": "97", "author": "G Attard", "year": "2012", "unstructured": "Attard G, Reid AHM, Auchus RJ et al (2012) Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer. J Clin Endocrinol Metab 97(2):507\u2013516", "journal-title": "J Clin Endocrinol Metab"}, {"key": "430_CR51", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1016/S0885-3924(02)00487-6", "volume": "24", "author": "C Gannon", "year": "2002", "unstructured": "Gannon C et al (2002) A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage 24:328\u2013334", "journal-title": "J Pain Symptom Manage"}, {"issue": "3", "key": "430_CR52", "doi-asserted-by": "publisher", "first-page": "625", "DOI": "10.1016/j.critrevonc.2013.07.015", "volume": "88", "author": "A Tuca", "year": "2013", "unstructured": "Tuca A, Jimenez-Fonseca P, Gasc\u00f3n P (2013) Clinical evaluation and optimal management of cancer cachexia. Crit Rev Oncol Hematol 88(3):625\u2013636. doi: 10.1016/j.critrevonc.2013.07.015 Epub 2013 Aug 15", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "430_CR53", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.clon.2005.08.015", "volume": "18", "author": "P Graham", "year": "2006", "unstructured": "Graham P et al (2006) A pilot randomised comparison of dexamethasone 96\u00a0mg vs 16\u00a0mg per day for malignant spinal cord compression treated by radiotherapy: tROG 01.05 Superdex study. Clin Oncol 18:70\u201376", "journal-title": "Clin Oncol"}, {"issue": "2", "key": "430_CR54", "first-page": "46", "volume": "5", "author": "J Hardy", "year": "1998", "unstructured": "Hardy J (1998) CA in palliative care. Eur J Palliat Med 5(2):46\u201350", "journal-title": "Eur J Palliat Med"}, {"key": "430_CR55", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1212/WNL.44.4.675", "volume": "44", "author": "CJ Vecht", "year": "1994", "unstructured": "Vecht CJ et al (1994) Dose effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumours: a randomised study of doses of 4, 8 and 16\u00a0mg a day. Neurology 44:675\u2013680", "journal-title": "Neurology"}, {"key": "430_CR56", "doi-asserted-by": "crossref", "first-page": "1035", "DOI": "10.1023/A:1008361102808", "volume": "10", "author": "D Feuer", "year": "1999", "unstructured": "Feuer D et al (1999) Systematic review and meta-analysis of CA for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 10:1035\u20131041", "journal-title": "Ann Oncol"}, {"issue": "4", "key": "430_CR57", "first-page": "CD001316", "volume": "2001", "author": "NP Rowell", "year": "2001", "unstructured": "Rowell NP et al (2001) Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction. Cochrane Database Syst Rev 2001(4):CD001316", "journal-title": "Cochrane Database Syst Rev"}, {"key": "430_CR58", "doi-asserted-by": "crossref", "first-page": "1437", "DOI": "10.1007/s00520-007-0305-0", "volume": "15", "author": "A Elsayem", "year": "2007", "unstructured": "Elsayem A, Bruera E (2007) High dose CA for the management of dyspnoea in patients with tumour obstruction of the upper airway. Support Care Cancer 15:1437\u20131439", "journal-title": "Support Care Cancer"}, {"key": "430_CR59", "doi-asserted-by": "crossref", "first-page": "1607", "DOI": "10.1002/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V", "volume": "33", "author": "C Moertel", "year": "1974", "unstructured": "Moertel C et al (1974) Corticosteroid therapy of pre-terminal gastro-intestinal cancer. Cancer 33:1607\u20131609", "journal-title": "Cancer"}, {"key": "430_CR60", "first-page": "1", "volume": "00", "author": "TB Dorff", "year": "2012", "unstructured": "Dorff TB, Crawford ED (2012) Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer. Ann Oncol 00:1\u20138", "journal-title": "Ann Oncol"}, {"key": "430_CR61", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1007/BF03346748", "volume": "36", "author": "K Esposito", "year": "2013", "unstructured": "Esposito K et al (2013) Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest 36:132\u2013139", "journal-title": "J Endocrinol Invest"}, {"key": "430_CR62", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.6004/jnccn.2010.0014", "volume": "8", "author": "PJ Saylor", "year": "2010", "unstructured": "Saylor PJ, Smith MR (2010) Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer. J Natl Compr Cancer Netw 8:211\u2013223", "journal-title": "J Natl Compr Cancer Netw"}, {"key": "430_CR63", "doi-asserted-by": "crossref", "first-page": "954", "DOI": "10.1093/clinids/11.6.954", "volume": "11", "author": "AE Stuck", "year": "1989", "unstructured": "Stuck AE, Minder CE, Frey FJ (1989) Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11:954\u2013963", "journal-title": "Rev Infect Dis"}, {"key": "430_CR64", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/S0090-4295(98)00149-6", "volume": "52", "author": "O Sartor", "year": "1998", "unstructured": "Sartor O, Weinberger M, Moore A et al (1998) Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer. Urology 52:252\u2013256", "journal-title": "Urology"}, {"key": "430_CR65", "doi-asserted-by": "publisher", "first-page": "893", "DOI": "10.1359/JBMR.040134", "volume": "19", "author": "JA Kanis", "year": "2004", "unstructured": "Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893\u2013899. doi: 10.1359/JBMR.040134", "journal-title": "J Bone Miner Res"}, {"key": "430_CR66", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1016/0039-6257(86)90077-9", "volume": "31", "author": "RC Urban", "year": "1986", "unstructured": "Urban RC, Cotlier E (1986) Corticosteroid-induced cataracts. Surv Ophthalmol 31:102\u2013110", "journal-title": "Surv Ophthalmol"}, {"issue": "10", "key": "430_CR67", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.4065/81.10.1361", "volume": "81", "author": "T Warrington", "year": "2006", "unstructured": "Warrington T, Bostwick M (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81(10):1361\u20131367", "journal-title": "Mayo Clin Proc"}, {"issue": "12", "key": "430_CR68", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1345/aph.1H418", "volume": "40", "author": "KA Hazlewood", "year": "2006", "unstructured": "Hazlewood KA, Fugate SA, Harrison DL (2006) Effect of oral corticosteroids on chronic warfarin therapy. Ann Pharmacother 40(12):2101\u20132106", "journal-title": "Ann Pharmacother"}, {"issue": "6", "key": "430_CR69", "doi-asserted-by": "publisher", "first-page": "R165", "DOI": "10.1530/EJE-13-0450", "volume": "169", "author": "A Grossman", "year": "2013", "unstructured": "Grossman A, Johannsson G, Quinkler M, Zelissen P (2013) Therapy of endocrine disease: perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol 169(6):R165\u2013R175. doi: 10.1530/EJE-13-0450 (Print 2013 Dec. Review.)", "journal-title": "Eur J Endocrinol"}, {"issue": "2", "key": "430_CR70", "first-page": "46", "volume": "5", "author": "J Hardy", "year": "1998", "unstructured": "Hardy J (1998) Corticosteroids in palliative care. Eur J Palliat Med 5(2):46\u201350", "journal-title": "Eur J Palliat Med"}, {"key": "430_CR71", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1186/1546-0096-10-31", "volume": "10", "author": "N Ilowite", "year": "2012", "unstructured": "Ilowite N, Sandborg C (2012) Feldman B: algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. Pediatr Rheumatol Online J 10:31", "journal-title": "Pediatr Rheumatol Online J"}, {"key": "430_CR72", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.2223/JPED.1773", "volume": "84", "author": "C Alves", "year": "2008", "unstructured": "Alves C, Robazzi TCV, Mendoca M (2008) Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr 84:192\u2013202", "journal-title": "J Pediatr"}, {"issue": "9", "key": "430_CR73", "doi-asserted-by": "crossref", "first-page": "1041", "DOI": "10.1007/s00520-007-0395-8", "volume": "16", "author": "A Sturdza", "year": "2008", "unstructured": "Sturdza A, Millar BA, Bana N, Laperriere N, Pond G, Wong RK et al (2008) The use and toxicity of steroids in the management of patients with brain metastases. Support Care Cancer 16(9):1041\u20131048", "journal-title": "Support Care Cancer"}, {"issue": "5", "key": "430_CR74", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1016/j.clon.2004.03.015", "volume": "16", "author": "BM Millar", "year": "2004", "unstructured": "Millar BM, Bezjak A, Tsao M, Sturdza A, Laperriere N (2004) Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases. Clin Oncol (R. Coll Radiol) 16(5):339\u2013344", "journal-title": "Clin Oncol (R. Coll Radiol)"}, {"issue": "4", "key": "430_CR75", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1212/WNL.44.4.675", "volume": "44", "author": "CJ Vecht", "year": "1994", "unstructured": "Vecht CJ, Hovestadt A, Verbiest HB, van Vliet JJ, van Putten WL (1994) Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16\u00a0mg per day. Neurology 44(4):675\u2013680", "journal-title": "Neurology"}, {"issue": "1", "key": "430_CR76", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1007/s11060-009-0057-4", "volume": "96", "author": "TC Ryken", "year": "2010", "unstructured": "Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL et al (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96(1):103\u2013114", "journal-title": "J Neurooncol"}, {"issue": "6", "key": "430_CR77", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1097/01376517-200412000-00008", "volume": "36", "author": "AE Nahaczewski", "year": "2004", "unstructured": "Nahaczewski AE, Fowler SB, Hariharan S (2004) Dexamethasone therapy in patients with brain tumors\u2014a focus on tapering. J Neurosci Nurs 36(6):340\u2013343", "journal-title": "J Neurosci Nurs"}, {"issue": "5", "key": "430_CR78", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1016/0090-3019(95)00252-9", "volume": "44", "author": "GC Szabo", "year": "1995", "unstructured": "Szabo GC, Winkler SR (1995) Withdrawal of glucocorticoid therapy in neurosurgical patients. Surg Neurol 44(5):498", "journal-title": "Surg Neurol"}, {"key": "430_CR79", "unstructured": "National Comprehensive Cancer Network (2013) NCCN Clinical Practice Guidelines in Oncology. Central nervous system cancers. Version 2.2013. Available at http://www.nccn.org/professionals/physiciangls/fguidelines.asp . Accessed 27 Feb 2013"}, {"key": "430_CR80", "unstructured": "Australian Cancer Network Adult Brain Tumour Guidelines Working Party (2009) Clinical practice guidelines for the management of adult gliomas: astrocytomas and oligodendrogliomas. Available at http://www.cancer.org.au/Healthprofessionals/clinicalguidelines/braintumours.htm . Accessed 27 Feb 2013"}, {"key": "430_CR81", "author": "R Twycross", "year": "2011", "edition": "4", "unstructured": "Twycross R, Wilcock A (2011) Palliative care formulary, 4th edn. Palliativedrugs.com Ltd, Nottingham", "volume-title": "Palliative care formulary"}, {"key": "430_CR82", "unstructured": "Kuhn JM, Pr\u00e9vost G (2014) How to manage the interruption of a treatment with anti-inflammatory corticosteroids? Presse Med. pii: S0755-4982(14)00057-8. doi: 10.1016/j.lpm.2014.01.007", "DOI": "10.1016/j.lpm.2014.01.007", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "430_CR83", "first-page": "838", "volume": "84", "author": "TA Abdu", "year": "1999", "unstructured": "Abdu TA, Elhadd TA, Neary R, Clayton RN (1999) Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamic-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 84(3):838\u2013843", "journal-title": "J Clin Endocrinol Metab"}], "container-title": ["Journal of Endocrinological Investigation"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s40618-016-0430-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s40618-016-0430-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s40618-016-0430-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 3]], "date-time": "2019-09-03T20:37:14Z", "timestamp": 1567543034000}, "score": 26.419853, "issued": {"date-parts": [[2016, 1, 19]]}, "references-count": 83, "journal-issue": {"published-print": {"date-parts": [[2016, 7]]}, "issue": "7"}, "alternative-id": ["430"], "URL": "http://dx.doi.org/10.1007/s40618-016-0430-z", "relation": {"cites": []}, "ISSN": ["1720-8386"], "issn-type": [{"value": "1720-8386", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:17:44Z", "timestamp": 1574731064765}, "publisher-location": "Hoboken, NJ", "reference-count": 295, "publisher": "John Wiley & Sons, Inc", "isbn-type": [{"value": "9781118771600", "type": "print"}, {"value": "9781118771723", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118771723.ch6", "type": "book-chapter", "created": {"date-parts": [[2015, 9, 26]], "date-time": "2015-09-26T06:53:11Z", "timestamp": 1443250391000}, "page": "145-187", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Recent Advances in Multicomponent Reaction Chemistry"], "prefix": "10.1002", "author": [{"given": "Christopher", "family": "Hulme", "sequence": "first", "affiliation": []}, {"given": "Muhammad", "family": "Ayaz", "sequence": "additional", "affiliation": []}, {"given": "Guillermo", "family": "Martinez-Ariza", "sequence": "additional", "affiliation": []}, {"given": "Federico", "family": "Medda", "sequence": "additional", "affiliation": []}, {"given": "Arthur", "family": "Shaw", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2015, 9, 26]]}, "reference": [{"key": "10.1002/9781118771723.ch6-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "4439", "DOI": "10.1021/cr800296p", "article-title": "Natural product synthesis using multicomponent reaction strategies", "volume": "109", "author": "Tour\u0117", "year": "2009", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB1.2|cit2", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2174/1386207013331291", "article-title": "The multicomponent reactions and their libraries for natural and preparative chemistry", "volume": "4", "author": "Ugi", "year": "2001", "journal-title": "Comb. Chem. High. Throughput Screen"}, {"key": "10.1002/9781118771723.ch6-BIB1.3|cit3", "author": "Knapp", "first-page": "27", "year": "2013", "volume-title": "Diversity-Oriented Synthesis", "DOI": "10.1002/9781118618110.ch2", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB1.4|cit4", "doi-asserted-by": "crossref", "first-page": "3168", "DOI": "10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U", "article-title": "Multicomponent reactions with isocyanides", "volume": "39", "author": "D\u00f6mling", "year": "2000", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB1.5|cit5", "first-page": "5", "year": "2014", "volume-title": "Multicomponent Reactions"}, {"key": "10.1002/9781118771723.ch6-BIB1.6|cit6", "author": "Zhu", "year": "2005", "volume-title": "Multicomponent Reactions", "DOI": "10.1002/3527605118", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB2|cit7", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1002/anie.199502591", "article-title": "Atom economy: a challenge for organic synthesis: homogeneous catalysis leads the way", "volume": "34", "author": "Trost", "year": "1995", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB2.2|cit8", "author": "Anastas", "year": "1998", "volume-title": "Green Chemistry: Theory and Practice"}, {"key": "10.1002/9781118771723.ch6-BIB2.3|cit9", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.3390/molecules17011074", "article-title": "Diversity oriented syntheses of conventional heterocycles by smart multi component reactions (MCRs) of the last decade", "volume": "17", "author": "Heiner", "year": "2012", "journal-title": "Molecules"}, {"key": "10.1002/9781118771723.ch6-BIB2.4|cit10", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1021/ar700155p", "article-title": "Function-oriented synthesis, step economy, and drug design", "volume": "41", "author": "Wender", "year": "2007", "journal-title": "Acc. Chem. Res."}, {"key": "10.1002/9781118771723.ch6-BIB2.5|cit11", "doi-asserted-by": "crossref", "first-page": "1964", "DOI": "10.1126/science.287.5460.1964", "article-title": "Target-oriented and diversity-oriented organic synthesis in drug discovery", "volume": "287", "author": "Schreiber", "year": "2000", "journal-title": "Science"}, {"key": "10.1002/9781118771723.ch6-BIB2.6|cit12", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1055/s-1999-2612", "article-title": "Discovery of new multi component reactions with combinatorial methods", "volume": "1999", "author": "Weber", "year": "1999", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB2.7|cit13", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1007/s11030-009-9111-6", "article-title": "Emerging molecular diversity from the intra-molecular Ugi reaction: iterative efficiency in medicinal chemistry", "volume": "13", "author": "Hulme", "year": "2009", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB3|cit14", "doi-asserted-by": "crossref", "first-page": "3321", "DOI": "10.1002/1521-3765(20000915)6:18<3321::AID-CHEM3321>3.0.CO;2-A", "article-title": "Maximizing synthetic efficiency: multi-component transformations lead the way", "volume": "6", "author": "Bienaym\u00e9", "year": "2000", "journal-title": "Chem. Eur. J."}, {"key": "10.1002/9781118771723.ch6-BIB4|cit15", "author": "Tuch", "first-page": "685", "year": "2005", "volume-title": "Handbook of Combinatorial Chemistry"}, {"key": "10.1002/9781118771723.ch6-BIB5|cit16", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1002/jlac.18500750103", "article-title": "Ueber die k\u00fcnstliche Bildung der Milchs\u00e4ure und einen neuen, dem Glycocoll homologen K\u00f6rper", "volume": "75", "author": "Strecker", "year": "1850", "journal-title": "Ann. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB6|cit17", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1055/s-1990-21229", "article-title": "Base-catalyzed autoxidation of \u03b1-aminonitriles: an efficient method for conversion of aldehydes to amides and 2-amino-2-sulfenylacetonitrile to carbamates", "volume": "12", "author": "Chuang", "year": "1990", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB6.2|cit18", "first-page": "1230", "article-title": "Solvent-free synthesis of racemic \u03b1-aminonitriles", "volume": "8", "author": "Baeza", "year": "2007", "journal-title": "Synthesis"}, {"key": "10.1002/9781118771723.ch6-BIB6.3|cit19", "doi-asserted-by": "crossref", "first-page": "8159", "DOI": "10.1016/j.tet.2008.06.047", "article-title": "Indium (III) iodide-mediated Strecker reaction in water: an efficient and environmentally friendly approach for the synthesis of \u03b1-aminonitrile via a three-component condensation", "volume": "64", "author": "Shen", "year": "2008", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB6.4|cit20", "doi-asserted-by": "crossref", "first-page": "2532", "DOI": "10.1021/jo052510n", "article-title": "Supramolecular catalysis of Strecker reaction in water under neutral conditions in the presence of \u03b2-cyclodextrin", "volume": "71", "author": "Surendra", "year": "2006", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB6.5|cit21", "doi-asserted-by": "crossref", "first-page": "6839", "DOI": "10.1039/b914151k", "article-title": "Lewis base-catalyzed three-component strecker reaction on water. An efficient manifold for the direct small \u03b1-cyanoamination of ketones and aldehydes", "volume": "44", "author": "Cruz-Acosta", "year": "2009", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB6.6|cit22", "doi-asserted-by": "crossref", "first-page": "3922", "DOI": "10.1016/j.tetlet.2010.05.088", "article-title": "One-pot three-component synthesis of \u03b1-aminonitriles using potassium hexacyanoferrate(II) as an eco-friendly cyanide source", "volume": "51", "author": "Li", "year": "2010", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB7|cit23", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/jlac.18822150102", "article-title": "Synthesis of pyridine derivatives from acetoacetic ester and aldehydeammoniak", "volume": "215", "author": "Hantzsch", "year": "1882", "journal-title": "Liebigs Ann. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB7.2|cit24", "first-page": "95", "article-title": "Hantzsch reaction: recent advances in Hantzsch 1,4-dihydropyridines", "volume": "67", "author": "Saini", "year": "2008", "journal-title": "J. Sci. Ind. Res."}, {"key": "10.1002/9781118771723.ch6-BIB8|cit25", "first-page": "360", "article-title": "The urea-aldehyde derivatives of acetoacetic esters", "volume": "23", "author": "Biginelli", "year": "1893", "journal-title": "Gazz. Chim. Ital."}, {"key": "10.1002/9781118771723.ch6-BIB8.2|cit26", "first-page": "66", "article-title": "Past, present and future of the Biginelli reaction: a critical perspective", "volume": "1", "author": "Suresh", "year": "2012", "journal-title": "Arkivoc"}, {"key": "10.1002/9781118771723.ch6-BIB9|cit27", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1002/ardp.19172550217", "article-title": "Synthesis of \u03b2-ketonic bases", "volume": "255", "author": "Mannich", "year": "1917", "journal-title": "Arch. Pharm."}, {"key": "10.1002/9781118771723.ch6-BIB9.2|cit28", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1039/CT9171100762", "article-title": "A synthesis of tropinone", "volume": "111", "author": "Robinson", "year": "1917", "journal-title": "J. Chem. Soc. London"}, {"key": "10.1002/9781118771723.ch6-BIB10|cit29", "first-page": "181", "article-title": "Isonitriles II. Compounds with aldehydes or with ketones monobasic organic acids", "volume": "51", "author": "Passerini", "year": "1921", "journal-title": "Gazz. Chim. Ital."}, {"key": "10.1002/9781118771723.ch6-BIB10.2|cit30", "doi-asserted-by": "crossref", "first-page": "3315", "DOI": "10.1021/jo026614z", "article-title": "1,4-thiazepines, 1,4-benzothiazepin-5-ones, and 1,4-benzothioxepin orthoamides via multicomponent reactions of isocyanides", "volume": "68", "author": "Marcaccini", "year": "2003", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB10.3|cit31", "doi-asserted-by": "crossref", "first-page": "2875", "DOI": "10.1021/ol016328u", "article-title": "A novel three-component butenolide synthesis", "volume": "3", "author": "Beck", "year": "2001", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB10.4|cit32", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1002/jlac.1991199101193", "article-title": "Studies on isocyanides and related compounds. Synthesis of oxazole derivatives via the Passerini reaction", "volume": "10", "author": "Bossio", "year": "1991", "journal-title": "Liebigs Ann. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB11|cit33", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1002/ange.19580702202", "article-title": "Einfache Synthesen und chemisches Verhalten neuer heterocyclischer Ringsysteme", "volume": "70", "author": "Asinger", "year": "1958", "journal-title": "Angew. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB11.2|cit34", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1002/cber.19620950123", "article-title": "Isonitrile, XI. Synthese einfacher Penicillans\u00e4ure-Derivate", "volume": "95", "author": "Ugi", "year": "1962", "journal-title": "Chem. Ber."}, {"key": "10.1002/9781118771723.ch6-BIB12|cit35", "first-page": "386", "article-title": "Studies on isonitriles", "volume": "71", "author": "Ugi", "year": "1959", "journal-title": "Angew. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB13|cit36", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1002/cber.19660990116", "article-title": "Heterocycles from CH-acidic nitriles VII 2-aminothiophene, carbonyl compounds, and sulfur", "volume": "99", "author": "Gewald", "year": "1966", "journal-title": "Chem. Ber. Recl."}, {"key": "10.1002/9781118771723.ch6-BIB14|cit37", "doi-asserted-by": "crossref", "first-page": "1153", "DOI": "10.1021/jo00427a012", "article-title": "Chemistry of sulfonylmethyl isocyanides. 12. Base-induced cycloaddition of sulfonylmethyl isocyanides to carbon, nitrogen double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides", "volume": "42", "author": "Van Leusen", "year": "1977", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB15|cit38", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1021/ja963178n", "article-title": "A new and practical synthesis of -amino acids from alkenyl boronic acids", "volume": "119", "author": "Petasis", "year": "1997", "journal-title": "J. Am. Chem. Soc."}, {"key": "10.1002/9781118771723.ch6-BIB16|cit39", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1055/s-1998-1721", "article-title": "Synthesis of imidazo[1,2-a] annulated pyridines, pyrazines and pyrimidines by a novel three-component condensation", "volume": "6", "author": "Groebke", "year": "1998", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB16.2|cit40", "doi-asserted-by": "crossref", "first-page": "2234", "DOI": "10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R", "article-title": "A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles", "volume": "37", "author": "Bienaym\u00e9", "year": "1998", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB16.3|cit41", "doi-asserted-by": "crossref", "first-page": "5469", "DOI": "10.1016/S0040-4039(98)01113-7", "article-title": "A three-component solid-phase synthesis of 3-aminoimidazo[1,2-a]azines", "volume": "39", "author": "Blackburn", "year": "1998", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB17|cit42", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/S0160-9327(05)80086-9", "article-title": "Multicomponent reactions in organic chemistry", "volume": "18", "author": "Ugi", "year": "1994", "journal-title": "Endeavour"}, {"key": "10.1002/9781118771723.ch6-BIB18|cit43", "doi-asserted-by": "crossref", "first-page": "4948", "DOI": "10.1039/c3cs35505e", "article-title": "Higher-order multicomponent reactions: beyond four reactants", "volume": "42", "author": "Brauch", "year": "2013", "journal-title": "Chem. Soc. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB19|cit44", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1002/anie.199305631", "article-title": "The seven-component reaction", "volume": "32", "author": "D\u00f6mling", "year": "1993", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB20|cit45", "doi-asserted-by": "crossref", "first-page": "632", "DOI": "10.1038/nprot.2007.71", "article-title": "The use of the Ugi four-component condensation", "volume": "2", "author": "Marcaccini", "year": "2007", "journal-title": "Nat. Protoc."}, {"key": "10.1002/9781118771723.ch6-BIB21|cit46", "author": "Ayaz", "first-page": "335", "year": "2012", "volume-title": "Isocyanide Chemistry", "DOI": "10.1002/9783527652532.ch10", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB22|cit47", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1021/jo048389m", "article-title": "A novel highly selective chiral auxiliary for the asymmetric synthesis of L- and D \u03b1-amino acid derivatives via a multicomponent Ugi reaction", "volume": "70", "author": "Basso", "year": "2005", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB23|cit48", "doi-asserted-by": "crossref", "first-page": "2574", "DOI": "10.1021/ja953868b", "article-title": "A remarkable two-step synthesis of diverse 1,4-benzodiazepine-2,5-diones using the Ugi four-component condensate ion products: 1-Isocyanocyclohexene as a convertible isocyanide. Mechanism of conversion, synthesis of diverse structures and demonstration of resin capture", "volume": "118", "author": "Keating", "year": "1996", "journal-title": "J. Am. Chem. Soc."}, {"key": "10.1002/9781118771723.ch6-BIB24|cit49", "doi-asserted-by": "crossref", "first-page": "7925", "DOI": "10.1016/S0040-4039(99)01580-4", "article-title": "Remarkable three step-one pot solution phase preparation of novel imidazolines utilizing a UDC (Ugi/de-Boc/cyclize) strategy", "volume": "40", "author": "Hulme", "year": "1999", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB25|cit50", "doi-asserted-by": "crossref", "first-page": "8021", "DOI": "10.1021/jo980622r", "article-title": "Improved procedure for the solution phase preparation of 1,4-benzodiazepine-2,5-dione libraries via Armstrong's convertible isonitrile and the Ugi reaction", "volume": "83", "author": "Hulme", "year": "1998", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB25.2|cit51", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1016/S0040-4039(97)10795-X", "article-title": "The solution phase synthesis of diketopiperazine libraries via the Ugi reaction: novel application of Armstrong's convertible isonitrile", "volume": "39", "author": "Hulme", "year": "1998", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB26|cit52", "doi-asserted-by": "crossref", "first-page": "1883", "DOI": "10.1016/S0040-4039(00)00052-6", "article-title": "Novel applications of convertible isonitriles for the synthesis of mono- and bi-cyclic \u03b3-lactam via a UDC strategy", "volume": "41", "author": "Hulme", "year": "2000", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB27|cit53", "doi-asserted-by": "crossref", "first-page": "8047", "DOI": "10.1016/S0040-4039(98)01770-5", "article-title": "Applications of N-BOC-diamines for the solution phase synthesis of ketopiperazine libraries utilizing a Ugi/De-BOC/Cyclization (UDC) strategy", "volume": "39", "author": "Hulme", "year": "1998", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB28|cit54", "doi-asserted-by": "crossref", "first-page": "7227", "DOI": "10.1016/S0040-4039(98)01593-7", "article-title": "Novel safety-catch linker and its application with a Ugi/De-Boc/Cyclization (UDC) strategy to access carboxylic acids, 1,4-benzodiazepines, diketopiperazines, ketopiperazines and dihydroquinoxalinones", "volume": "39", "author": "Hulme", "year": "1998", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB29|cit55", "doi-asserted-by": "crossref", "first-page": "5295", "DOI": "10.1016/S0040-4039(99)00960-0", "article-title": "Novel applications of ethyl glyoxylate with the Ugi MCR", "volume": "40", "author": "Hulme", "year": "1999", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB30|cit56", "doi-asserted-by": "crossref", "first-page": "4959", "DOI": "10.1016/S0040-4039(01)00919-4", "article-title": "Two-step solution-phase synthesis of novel benzimidazoles utilizing a UDC (Ugi/De-Boc/Cyclize) strategy", "volume": "42", "author": "Tempest", "year": "2001", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB31|cit57", "doi-asserted-by": "crossref", "first-page": "1637", "DOI": "10.1016/S0040-4039(02)00101-6", "article-title": "Two-step solution-phase synthesis of novel quinoxalinones utilizing a UDC (Ugi/De-Boc/Cyclize) strategy", "volume": "43", "author": "Nixey", "year": "2002", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB32|cit58", "doi-asserted-by": "crossref", "first-page": "3951", "DOI": "10.1016/j.tetlet.2010.05.108", "article-title": "Concise two-step solution phase syntheses of four novel dihydroquinazoline scaffolds", "volume": "51", "author": "Dietrich", "year": "2010", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB33|cit59", "doi-asserted-by": "crossref", "first-page": "3681", "DOI": "10.1016/S0040-4039(02)00636-6", "article-title": "Short solution phase preparation of fused azepine-tetrazoles via UDC (Ugi/De-Boc/Cyclize) strategy", "volume": "43", "author": "Nixey", "year": "2002", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB34|cit60", "doi-asserted-by": "crossref", "first-page": "8729", "DOI": "10.1016/S0040-4039(00)01563-X", "article-title": "The one-pot solution-phase preparation of fused tetrazole-ketopiperazines", "volume": "41", "author": "Nixey", "year": "2000", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB35|cit61", "doi-asserted-by": "crossref", "first-page": "1939", "DOI": "10.1016/j.tetlet.2009.02.099", "article-title": "An efficient solution phase synthesis of triazadibenzoazulenones: \u201cdesigner isonitrile free\u201d\ufe01 methodology enabled by microwaves", "volume": "50", "author": "Hulme", "year": "2009", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB36|cit62", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1007/s11030-011-9354-x", "article-title": "Facile, novel two-step syntheses of benzimidazoles, bis-benzimidazoles, and bis-benzimidazole-dihydroquinoxalines", "volume": "16", "author": "Xu", "year": "2012", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB37|cit63", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1007/s11030-012-9374-1", "article-title": "Applications of ortho-phenylisonitrile and ortho-N-Boc aniline for the two-step preparation of novel bis-heterocyclic chemotypes", "volume": "16", "author": "Xu", "year": "2012", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB38|cit64", "doi-asserted-by": "crossref", "first-page": "4566", "DOI": "10.1016/j.tetlet.2010.06.116", "article-title": "Two-step syntheses of fused quinoxaline-benzodiazepines and bis-benzodiazepines", "volume": "51", "author": "Xu", "year": "2010", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB39|cit65", "doi-asserted-by": "crossref", "first-page": "460", "DOI": "10.1021/co300046r", "article-title": "General one-pot, two-step protocol accessing a range of novel polycyclic heterocycles with high skeletal diversity", "volume": "14", "author": "Xu", "year": "2012", "journal-title": "ACS Comb. Sci."}, {"key": "10.1002/9781118771723.ch6-BIB40|cit66", "first-page": "225", "article-title": "Expeditious routes to polycyclic molecular frameworks via one-pot, two-step Ugi ring-closing sequences", "volume": "25", "author": "Xu", "year": "2014", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB41|cit67", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1021/cr0505728", "article-title": "Recent developments in isocyanide based multicomponent reactions in applied chemistry", "volume": "106", "author": "D\u00f6mling", "year": "2006", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB41.2|cit68", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.2174/0929867033368600", "article-title": "\u201cMulti-component reactions: emerging chemistry in drug discovery\u201d\ufe01 \u201cfrom Xylocain to Crixivan\u201d\ufe01", "volume": "10", "author": "Hulme", "year": "2003", "journal-title": "Curr. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB42|cit69", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1111/j.1747-0285.2005.00314.x", "article-title": "Overcoming roadblocks in lead optimization: a thermodynamic perspective", "volume": "67", "author": "Ruben", "year": "2006", "journal-title": "Chem. Biol. Drug. Des."}, {"key": "10.1002/9781118771723.ch6-BIB43|cit70", "doi-asserted-by": "crossref", "first-page": "5866", "DOI": "10.1021/ol402940x", "article-title": "Highly diastereoselective synthesis of 1-carbamoyl-4-aminoindoloazepinone derivatives via the Ugi reaction", "volume": "15", "author": "Jida", "year": "2013", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB44|cit71", "author": "Shkirando", "first-page": "104", "year": "2009", "volume-title": "Proceedings of the 4th International Conference on Multi-Component Reactions and Related Chemistry, Ekaterinburg, Russia"}, {"key": "10.1002/9781118771723.ch6-BIB45|cit72", "doi-asserted-by": "crossref", "first-page": "3315", "DOI": "10.1021/jo026614z", "article-title": "1,4-thiazepines, 1,4-benzothiazepin-5-ones and 1,4-benzothioxepinorthoamides via multicomponent reactions of isocyanides", "volume": "68", "author": "Marcaccini", "year": "2003", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB46|cit73", "doi-asserted-by": "crossref", "first-page": "6036", "DOI": "10.1039/c3ob40900g", "article-title": "Bifunctional building blocks in the Ugi-azide condensation reaction: a general strategy toward exploration of new molecular diversity", "volume": "11", "author": "Gunawan", "year": "2013", "journal-title": "Org. Biomol. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB47|cit74", "doi-asserted-by": "crossref", "first-page": "1851", "DOI": "10.1016/S0040-4039(99)00072-6", "article-title": "Preparation of tricyclic nitrogen heterocycles via tandem four-component condensation/intramolecular Diels-Alder reaction", "volume": "40", "author": "Paulvannan", "year": "1999", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB48|cit75", "doi-asserted-by": "crossref", "first-page": "1207", "DOI": "10.1021/jo030231z", "article-title": "An atom-economical approach to conformationally constrained tricyclic nitrogen heterocycles via sequential and tandem Ugi/intramolecular Diels\u2212Alder reaction of pyrrole", "volume": "69", "author": "Paulvannan", "year": "2004", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB49|cit76", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1016/S0040-4039(01)02299-7", "article-title": "Studies on the sequential multi-component coupling/Diels-Alder cycloaddition reaction", "volume": "43", "author": "Wright", "year": "2002", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB50|cit77", "doi-asserted-by": "crossref", "first-page": "9544", "DOI": "10.1021/jo061825f", "article-title": "Complexity-enhancing acid-promoted rearrangement of tricyclic products of tandem Ugi 4CC/intramolecular Diels\u2212Alder reaction", "volume": "71", "author": "Ilyin", "year": "2006", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB51|cit78", "doi-asserted-by": "crossref", "first-page": "8859", "DOI": "10.1021/jo901628a", "article-title": "One-pot facile synthesis of substituted isoindolinones via an Ugi four-component condensation/Diels\u2212Alder cycloaddition/deselenization-aromatization sequence", "volume": "74", "author": "Huang", "year": "2009", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB52|cit79", "doi-asserted-by": "crossref", "first-page": "8189", "DOI": "10.1016/S0040-4020(99)00300-2", "article-title": "Ring closing metathesis in organic synthesis: evolution of a high speed, solid phase method for the preparation of \u03b2-turn mimetics", "volume": "55", "author": "Piscopio", "year": "1999", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB53|cit80", "unstructured": "Vo-Thanh , G. Boucard , V. Sauriat-Dorizon , H. Guib\u00e9 , F. 2001 Ring closing metathesis of unsaturated amides as a route to short and medium-sized unsaturated lactams and to ethylenic pseudopeptides Synlett 37 40", "DOI": "10.1002/chin.200117073", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB54|cit81", "doi-asserted-by": "crossref", "first-page": "7655", "DOI": "10.1016/j.tetlet.2003.08.027", "article-title": "Application of tandem Ugi reaction/ring-closing metathesis in multicomponent synthesis of unsaturated nine-membered lactams", "volume": "44", "author": "Banfi", "year": "2003", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB55|cit82", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1039/b414374d", "article-title": "Application of tandem Ugi multi-component reaction/ring closing metathesis to the synthesis of a conformationally restricted cyclic pentapeptide", "volume": "3", "author": "Dietrich", "year": "2005", "journal-title": "Org. Biomol. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB56|cit83", "doi-asserted-by": "crossref", "first-page": "5987", "DOI": "10.1016/j.tetlet.2004.06.052", "article-title": "Preparation of peptide-like bicyclic lactams via a sequential Ugi reaction-olefin metathesis approach", "volume": "45", "author": "Krelaus", "year": "2004", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB57|cit84", "doi-asserted-by": "crossref", "first-page": "8830", "DOI": "10.1016/j.tet.2006.06.061", "article-title": "Preparation of optically pure fused polycyclic scaffolds by Ugi reaction followed by olefin and enyne metathesis", "volume": "62", "author": "Basso", "year": "2006", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB58|cit85", "doi-asserted-by": "crossref", "first-page": "5119", "DOI": "10.1021/ol7023373", "article-title": "Concise construction of novel bridged bicyclic lactams by sequenced Ugi/RCM/Heck reactions", "volume": "9", "author": "Ribelin", "year": "2007", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB59|cit86", "doi-asserted-by": "crossref", "first-page": "4963", "DOI": "10.1016/S0040-4039(01)00920-0", "article-title": "MCC/SNAr methodology. Part 1: novel access to a range of heterocyclic cores", "volume": "42", "author": "Tempest", "year": "2001", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB60|cit87", "doi-asserted-by": "crossref", "first-page": "1947", "DOI": "10.1016/S0040-4039(03)00084-4", "article-title": "MCC/SNAr methodology. Part 2: novel three-step solution phase access to libraries of benzodiazepines", "volume": "44", "author": "Tempest", "year": "2003", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB61|cit88", "doi-asserted-by": "crossref", "first-page": "4079", "DOI": "10.1021/ol0168420", "article-title": "A rapid access to biaryl ether containing macrocycles by pairwise use of Ugi-4CR and intramolecular SNAr-based cycloetherification", "volume": "3", "author": "Cristau", "year": "2001", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB62|cit89", "doi-asserted-by": "crossref", "first-page": "7859", "DOI": "10.1016/j.tet.2003.08.031", "article-title": "Rapid and diverse route to natural product-like biaryl ether containing macrocycles", "volume": "59", "author": "Cristau", "year": "2003", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB63|cit90", "doi-asserted-by": "crossref", "first-page": "5575", "DOI": "10.1016/S0040-4039(03)01378-9", "article-title": "Solid-phase synthesis of natural product-like macrocycles by a sequence of Ugi-4CR and SNAr-based cycloetherification", "volume": "44", "author": "Cristau", "year": "2003", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB64|cit91", "doi-asserted-by": "crossref", "first-page": "4774", "DOI": "10.1002/anie.200351923", "article-title": "One-pot synthesis of polyheterocycles by a Palladium-catalyzed intramolecular N-arylation/C-H activation/aryl-aryl bond-forming domino process", "volume": "42", "author": "Cuny", "year": "2003", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB65|cit92", "doi-asserted-by": "crossref", "first-page": "14475", "DOI": "10.1021/ja047472o", "article-title": "Palladium- and copper-catalyzed synthesis of medium- and large-sized ring-fused dihydroazaphenanthrenes and 1,4-benzodiazepine-2,5-diones. Control of reaction pathway by metal-switching", "volume": "126", "author": "Cuny", "year": "2004", "journal-title": "J. Am. Chem. Soc."}, {"key": "10.1002/9781118771723.ch6-BIB66|cit93", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1021/ol7029799", "article-title": "Palladium-catalyzed domino intramolecular N-arylation/ intermolecular C-C bond formation for the synthesis of functionalized benzodiazepinediones", "volume": "10", "author": "Salcedo", "year": "2008", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB67|cit94", "doi-asserted-by": "crossref", "first-page": "3423", "DOI": "10.1016/j.tetlet.2006.03.069", "article-title": "Highly substituted indol-2-ones, quinoxalin-2-ones and benzodiazepin-2,5-diones via a new Ugi(4CR)-Pd assisted N-aryl amidation strategy", "volume": "47", "author": "Kalinski", "year": "2006", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB68|cit95", "doi-asserted-by": "crossref", "first-page": "4351", "DOI": "10.1021/ol061755z", "article-title": "Rapid access to oxindoles by the combined use of an Ugi four-component reaction and a microwave-assisted intramolecular Buchwald\u2212Hartwig amidation reaction", "volume": "8", "author": "Bonnaterre", "year": "2006", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB69|cit96", "doi-asserted-by": "crossref", "first-page": "3109", "DOI": "10.1021/jo900210x", "article-title": "Ugi-post functionalization, from a single set of Ugi-adducts to two distinct Heterocycles by microwave-assisted Palladium-catalyzed cyclizations: Tuning the reaction pathways by ligand switch", "volume": "74", "author": "Erb", "year": "2009", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB70|cit97", "doi-asserted-by": "crossref", "first-page": "500", "DOI": "10.1055/s-2007-968026", "article-title": "New Ugi/Pictet-Spengler multicomponent formation of polycyclic diketopiperazines from isocyanides and \u03b1-keto acids", "volume": "2007", "author": "El Kaim", "year": "2007", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB71|cit98", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1021/jo102058s", "article-title": "Polycyclic compounds by Ugi\u2212Pictet\u2212Spengler sequence", "volume": "76", "author": "Wang", "year": "2011", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB72|cit99", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1039/B917660H", "article-title": "Polycyclic indole alkaloid-type compounds by MCR", "volume": "46", "author": "Wang", "year": "2010", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB73|cit100", "doi-asserted-by": "crossref", "first-page": "7706", "DOI": "10.1039/c0cc02938f", "article-title": "Asymmetric synthesis of synthetic alkaloids by a tandem biocatalysis/Ugi/Pictet-Spengler-type cyclization sequence", "volume": "46", "author": "Znabet", "year": "2010", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB74|cit101", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1021/ol070164l", "article-title": "Synthesis of novel and uniquely shaped 3-azabicyclo[4.2.0]octan-4-one derivatives by sequential Ugi/[2+2] ene\u2212enone photocycloadditions", "volume": "9", "author": "Akritopoulou-Zanze", "year": "2007", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB75|cit102", "doi-asserted-by": "crossref", "first-page": "8037", "DOI": "10.1002/anie.201202575", "article-title": "Ugi/aldol sequence: expeditious entry to several families of densely substituted nitrogen heterocycles", "volume": "51", "author": "Xu", "year": "2012", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB75.2|cit103", "doi-asserted-by": "crossref", "first-page": "2738", "DOI": "10.1021/ol401068u", "article-title": "Aldol reactions in multicomponent reaction based domino pathways: a multipurpose enabling tool in heterocyclic chemistry", "volume": "15", "author": "Xu", "year": "2013", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB76|cit104", "doi-asserted-by": "crossref", "first-page": "958", "DOI": "10.1021/cc050099b", "article-title": "A concise and diversity oriented strategy for the synthesis of benzofurans and indoles via Ugi and Diels-Alder reactions", "volume": "7", "author": "Lu", "year": "2005", "journal-title": "J. Comb. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB77|cit105", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1021/ol035787n", "article-title": "Highly substituted pyrrolidinones and pyridones by 4-CR/2-CR sequence", "volume": "6", "author": "Beck", "year": "2004", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB78|cit106", "first-page": "327", "article-title": "Multicomponent synthesis of highly substituted 2-pyridones", "volume": "2", "author": "Neo", "year": "2007", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB79|cit107", "doi-asserted-by": "crossref", "first-page": "2592", "DOI": "10.1016/j.tetlet.2012.03.033", "article-title": "Hydrazine-mediated cyclization of ugi products to synthesize novel 3-hydroxypyrazoles", "volume": "53", "author": "Shaw", "year": "2012", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB80|cit108", "doi-asserted-by": "crossref", "first-page": "1998", "DOI": "10.1016/j.tetlet.2012.02.030", "article-title": "Ugi/Robinson-Gabriel reactions directed toward the synthesis of 2, 4, 5-trisubstituted oxazoles", "volume": "53", "author": "Shaw", "year": "2012", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB81|cit109", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1016/j.tetlet.2004.11.083", "article-title": "A facile synthesis of 1, 4-benzodiazepine derivatives via Ugi four-component condensation", "volume": "46", "author": "Marcaccini", "year": "2005", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB82|cit110", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1016/0040-4039(95)02310-0", "article-title": "Synthesis of tetrasubstituted imidazoles via \u03b1-(N-acyl-N-alkylamino)-\u03b2-ketoamides on Wang resin", "volume": "37", "author": "Zhang", "year": "1996", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB82.2|cit111", "doi-asserted-by": "crossref", "first-page": "5599", "DOI": "10.1016/S0040-4020(02)00550-1", "article-title": "Facile two-pot syntheses of novel alternating benzene/imidazole systems", "volume": "58", "author": "Sung", "year": "2002", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB83|cit112", "doi-asserted-by": "crossref", "first-page": "1705", "DOI": "10.1016/j.tetlet.2009.01.124", "article-title": "Tetramic acid derivatives via Ugi-Dieckmann-reaction", "volume": "50", "author": "Spatz", "year": "2009", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB84|cit113", "doi-asserted-by": "crossref", "first-page": "2225", "DOI": "10.1016/j.tet.2007.12.028", "article-title": "Synthesis of pseudopeptidic [(5H)-6-oxodibenzo[b,f][1,5]diazocine-5-yl]arylglycinamides by an Ugi 4CC/Staudinger/aza-Wittig sequence", "volume": "64", "author": "Corres", "year": "2008", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB85|cit114", "doi-asserted-by": "crossref", "first-page": "4578", "DOI": "10.1021/jo060434y", "article-title": "Synthesis of 3-hydroxy-6-oxo[1,2,4]triazin-1-yl alaninamides, a new class of cyclic dipeptidyl ureas", "volume": "71", "author": "Sa\u00f1udo", "year": "2006", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB86|cit115", "doi-asserted-by": "crossref", "first-page": "6783", "DOI": "10.1016/j.tet.2010.06.062", "article-title": "Synthesis of pseudopeptidic (S)-6-amino-5-oxo-1,4-diazepines and (S)-3-benzyl-2-oxo-1,4-benzodiazepines by an Ugi 4CC/Staudinger/aza-Wittig sequence", "volume": "66", "author": "Lecinska", "year": "2010", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB87|cit116", "doi-asserted-by": "crossref", "first-page": "3714", "DOI": "10.1016/j.tet.2011.03.056", "article-title": "New efficient synthesis of 2,3,4-trisubstituted 3,4-dihydroquinazolines by a Ugi 4CC/Staudinger/aza-Wittig sequence", "volume": "67", "author": "Zhong", "year": "2011", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB88|cit117", "doi-asserted-by": "crossref", "first-page": "1429", "DOI": "10.1039/c0ob00855a", "article-title": "Unexpected synthesis of indolo[1,2-c]quinazolines by a sequential Ugi 4CC-Staudinger-aza-Wittig-nucleophilic addition reaction", "volume": "9", "author": "He", "year": "2011", "journal-title": "Org. Biomol. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB89|cit118", "doi-asserted-by": "crossref", "first-page": "4236", "DOI": "10.1039/b613056a", "article-title": "Multicomponent synthesis of dihydrobenzoxazepinones by coupling Ugi and Mitsunobu reactions", "volume": "4", "author": "Banfi", "year": "2006", "journal-title": "Org. Biomol. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB90|cit119", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1007/s11030-009-9210-4", "article-title": "Multicomponent synthesis of dihydrobenzoxazepinones, bearing four diversity points, as potential \u03b1-helix mimics", "volume": "14", "author": "Banfi", "year": "2010", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB91|cit120", "doi-asserted-by": "crossref", "first-page": "2151", "DOI": "10.1021/jo062626z", "article-title": "Ugi multicomponent reaction followed by an intramolecular nucleophilic substitution:\u2009 convergent multicomponent synthesis of 1-sulfonyl 1,4-diazepan-5-ones and of their benzo-fused derivatives", "volume": "72", "author": "Banfi", "year": "2007", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB92|cit121", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1007/s11030-008-9087-7", "article-title": "Multicomponent synthesis of benzoxazinones via tandem Ugi/Mitsunobu reactions: an unexpected cine-substitution", "volume": "12", "author": "Banfi", "year": "2008", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB93|cit122", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1002/ejoc.201001077", "article-title": "Tandem Ugi MCR/Mitsunobu cyclization as a short, protecting-group-free route to benzoxazinones with four diversity points", "volume": "2011", "author": "Banfi", "year": "2011", "journal-title": "Eur. J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB94|cit123", "doi-asserted-by": "crossref", "first-page": "6774", "DOI": "10.1016/j.tet.2006.05.001", "article-title": "Microwave-assisted one-pot U-4CR and intramolecular O-alkylation toward heterocyclic scaffolds", "volume": "62", "author": "Xing", "year": "2006", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB95|cit124", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1021/cc060066b", "article-title": "Synthesis of functionalized quinolines via Ugi and Pd-catalyzed intramolecular arylation reactions", "volume": "8", "author": "Ma", "year": "2006", "journal-title": "J. Comb. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB96|cit125", "doi-asserted-by": "crossref", "first-page": "3155", "DOI": "10.1021/ol048791n", "article-title": "Concise synthesis of isoquinoline via the Ugi and Heck reactions", "volume": "6", "author": "Xiang", "year": "2004", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB97|cit126", "doi-asserted-by": "crossref", "first-page": "11657", "DOI": "10.1016/0040-4020(96)00647-3", "article-title": "Ugi reactions with trifunctional \u03b1-amino acids, aldehydes, isocyanides and alcohols", "volume": "52", "author": "Ugi", "year": "1996", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB98|cit127", "doi-asserted-by": "crossref", "first-page": "2391", "DOI": "10.1016/j.tetlet.2006.01.149", "article-title": "A new and versatile one-pot synthesis of indol-2-ones by a novel Ugi-four-component-Heck reaction", "volume": "47", "author": "Umkehrer", "year": "2006", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB99|cit128", "doi-asserted-by": "crossref", "first-page": "4683", "DOI": "10.1016/j.tetlet.2006.04.127", "article-title": "A novel one-pot synthesis of highly diverse indole scaffolds by the Ugi/Heck reaction", "volume": "47", "author": "Kalinski", "year": "2006", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB100|cit129", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1055/s-1994-25565", "article-title": "Studies on isocyanides and related compounds: a novel synthesis of pyrroles via Ugi reaction", "volume": "1994", "author": "Bossio", "year": "1994", "journal-title": "Synthesis"}, {"key": "10.1002/9781118771723.ch6-BIB101|cit130", "unstructured": "Marcosa , C. F. Marcaccini , S. Pepino , R. Poloa , C. Torroba , T. 2003 Studies on isocyanides and related compounds: a facile synthesis of functionalized 3(2 H )-pyridazinones via Ugi four-component condensation Synthesis 691 694", "DOI": "10.1002/chin.200328172", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB102|cit131", "doi-asserted-by": "crossref", "first-page": "3999", "DOI": "10.1016/j.tetlet.2004.03.184", "article-title": "One-pot synthesis of quinolin-2-(1H)-ones via tandem Ugi-Knoevenagel condensations", "volume": "45", "author": "Marcaccini", "year": "2004", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB103|cit132", "doi-asserted-by": "crossref", "first-page": "4529", "DOI": "10.1021/jo980248v", "article-title": "A one-pot synthesis of 1-(2,2,6,6-tetramethyl-4-piperidinyl)-4- (4-fluorophenyl)-5-(2-amino-4-pyrimidinyl)- imidazole: A potent inhibitor of p38 MAP kinase", "volume": "63", "author": "Sisko", "year": "1998", "journal-title": "J Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB104|cit133", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.3987/S-1977-01-0077", "article-title": "Synthesis of oxazoles, imidazoles and pyrroles with the use of mono-substituted tosylmethyl isocyanides", "volume": "7", "author": "Possel", "year": "1977", "journal-title": "Heterocycles"}, {"key": "10.1002/9781118771723.ch6-BIB104.2|cit134", "doi-asserted-by": "crossref", "first-page": "5337", "DOI": "10.1016/S0040-4039(01)85244-8", "article-title": "A new and simple synthesis of the pyrrole ring system from Michael acceptors and tosylmethylisocyanides", "volume": "13", "author": "Van Leusen", "year": "1972", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB104.3|cit135", "unstructured": "Have , R. Leusink , F. R. Van Leusen , A. M. 1996 An efficient synthesis of substituted 3(4)-nitropyrroles from nitroalkenes and tosylmethyl isocyanides Synthesis 871 876", "DOI": "10.1055/s-1996-4306", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB105|cit136", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1002/ange.19780900221", "article-title": "Asymmetrische synthese von \u03b1-alkyl-\u03b1-aminocarbons\u00e4uren durch alkylierung von 1-chiral-substituierten 2-imidazolin-5-one", "volume": "90", "author": "Schollkopf", "year": "1978", "journal-title": "Angew. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB105.2|cit137", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1002/jlac.198119810311", "article-title": "Asymmetrische Synthesen \u00fcber heterocyclische Zwischenstufen, IV Asymmetrische Synthese von \u03b1-Methylphenylalanin und seinen Analoga durch Alkylieren von 1-chiral substituiertem 4-Methyl-2-imidazolin-5-one", "volume": "3", "author": "Schollkopf", "year": "1981", "journal-title": "Liebigs Ann. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB106|cit138", "unstructured": "Suzuki , M. Moriya , T. Matsumoto , K. Miyoshi , M. 1982 Synthesis of 7,10-disubstituted benzo[ b ]phenazine-6,11-quinones Synthesis 874 875", "DOI": "10.1055/s-1982-29986", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB106.2|cit139", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.3987/R-1987-03-0651", "article-title": "Observations on the reactions of isocyanoacetane esters with isothiocyanates and isocyanates", "volume": "26", "author": "Solomon", "year": "1987", "journal-title": "Heterocycles"}, {"key": "10.1002/9781118771723.ch6-BIB107|cit140", "doi-asserted-by": "crossref", "first-page": "1982", "DOI": "10.1002/jlac.197819781213", "article-title": "Total synthese von 2,2-Diethyl-3-methyl-und-2,2-Diethyl-3,6-dimethyl-6-(phenoxyacetamido)penam-3-carbonsaure", "volume": "8", "author": "Meyer", "year": "1978", "journal-title": "Liebigs Ann. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB108|cit141", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1002/jhet.5570170417", "article-title": "Heterocycles from substituted amides. VIII Oxazole derivatives from reaction of isocyanates with 2-isocyanoacetamides", "volume": "17", "author": "Chupp", "year": "1980", "journal-title": "J. Heterocycl. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB109|cit142", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1002/cber.19761090210", "article-title": "Cycloaddition von \u201cIsocyanketen\u201d\ufe01 an Benzophenonanilund Thioimids\u00e4ureester zu \u03b2-Lactamen", "volume": "109", "author": "Hoppe", "year": "1976", "journal-title": "Chem. Ber."}, {"key": "10.1002/9781118771723.ch6-BIB109.2|cit143", "doi-asserted-by": "crossref", "first-page": "4681", "DOI": "10.1016/S0040-4039(01)80773-5", "article-title": "Asymmetric aldol reaction of \u03b1-ketoesters with isocyanoacetate and isocyanoacetamide catalyzed by a chiral ferrocenylphosphine-gold(I) complex", "volume": "30", "author": "Ito", "year": "1989", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB110|cit144", "doi-asserted-by": "crossref", "first-page": "4879", "DOI": "10.1021/jo050029r", "article-title": "Heterocyclizations with tosylmethyl isocyanide derivatives. A new approach to substituted azolopyrimidines", "volume": "70", "author": "Beaza", "year": "2005", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB111|cit145", "doi-asserted-by": "crossref", "first-page": "1354", "DOI": "10.1021/ol3003282", "article-title": "Straightforward assembly of phenylimidazoquinoxalines via a one-pot two-step MCR process", "volume": "14", "author": "De Moliner", "year": "2012", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB112|cit146", "doi-asserted-by": "crossref", "first-page": "9415", "DOI": "10.1021/jo4016425", "article-title": "Catalytic asymmetric Petasis reactions of vinylboronates", "volume": "78", "author": "Shi", "year": "2013", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB113|cit147", "doi-asserted-by": "crossref", "first-page": "9017", "DOI": "10.1016/j.tetlet.2003.09.218", "article-title": "Synthesis of novel cyclic \u03b1-amino acid derivatives via a one-pot sequential Petasis reaction/palladium catalysed process", "volume": "44", "author": "Grigg", "year": "2003", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB114|cit148", "first-page": "221", "article-title": "A traceless, solid-supported synthesis of \u03b2-turn mimetics based on the hexahydropyrazino[1,2-a]pyrazine-1,2-dione scaffold", "volume": "2", "author": "Mieczkowski", "year": "2010", "journal-title": "Synthesis"}, {"key": "10.1002/9781118771723.ch6-BIB115|cit149", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1021/cc900092x", "article-title": "One-pot synthesis of new fused 4,5-bridged 1,2,5-triazepine-3,6-diones, 1,2,5-triazepine-3,7-diones heterocycles by Petasis reaction", "volume": "12", "author": "Neogi", "year": "2010", "journal-title": "J. Comb. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB116|cit150", "doi-asserted-by": "crossref", "first-page": "9607", "DOI": "10.1016/S0040-4039(00)01717-2", "article-title": "Synthesis of piperazinones and benzopiperazinones from 1,2-diamines and organoboronic acids", "volume": "41", "author": "Petasis", "year": "2000", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB117|cit151", "doi-asserted-by": "crossref", "first-page": "1747", "DOI": "10.1016/j.jorganchem.2008.11.050", "article-title": "Synthesis of 2H-chromenes and 1,2-dihydroquinolines from aryl aldehydes, amines, and alkenylboron compounds", "volume": "694", "author": "Petasis", "year": "2009", "journal-title": "J. Organomet. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB118|cit152", "doi-asserted-by": "crossref", "first-page": "4821", "DOI": "10.1016/j.tetlet.2011.06.115", "article-title": "A novel route to synthesize libraries of quinoxalines via Petasis methodology in two synthetic operations", "volume": "52", "author": "Ayaz", "year": "2011", "journal-title": "Tetrahedron. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB119|cit153", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/s11030-008-9072-1", "article-title": "Emerging approaches for the syntheses of bicyclic imidazo[1,2-x]-heterocycles", "volume": "12", "author": "Hulme", "year": "2008", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB119.2|cit154", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1080/00397910902953331", "article-title": "Trimethylsilyl chloride as a promoter for the Groebke-Blackburn reaction: preparation of imidazo[2,1-b][1,3]benzothiazoles", "volume": "40", "author": "Tsirulnikov", "year": "2009", "journal-title": "Synth. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB120|cit155", "doi-asserted-by": "crossref", "first-page": "8355", "DOI": "10.1016/j.tetlet.2005.09.181", "article-title": "New multicomponent reaction accessing 3-aminoimidazo[1,2-a]pyridines", "volume": "46", "author": "Schwerloske", "year": "2005", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB121|cit156", "doi-asserted-by": "crossref", "first-page": "2213", "DOI": "10.1016/j.tetlet.2007.01.061", "article-title": "Expeditious synthesis of imidazo[1,2-c]pyrimidines via a [4+1]-cycloaddition", "volume": "48", "author": "Umkehrer", "year": "2007", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB122|cit157", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/j.drudis.2006.10.012", "article-title": "Knowledge based chemoinformatics approaches to drug discovery", "volume": "11", "author": "Ghose", "year": "2006", "journal-title": "Drug Discov. Today"}, {"key": "10.1002/9781118771723.ch6-BIB123|cit158", "doi-asserted-by": "crossref", "first-page": "6891", "DOI": "10.1016/j.tetlet.2006.07.037", "article-title": "Air-oxidized products of multi-component reactions between 3-amino-1,2,4-triazole, aromatic aldehydes and isonitriles", "volume": "47", "author": "Parchinsky", "year": "2006", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB124|cit159", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1002/jccs.200800043", "article-title": "A novel, simple and efficient synthesis of 3-amino-benzo[d]imidazo[2,1-b]thiazole derivatives via a multicomponent procedure", "volume": "55", "author": "Sun", "year": "2008", "journal-title": "J. Chin. Chem. Soc."}, {"key": "10.1002/9781118771723.ch6-BIB125|cit160", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/j.cbpa.2010.03.003", "article-title": "Recent advances in multicomponent reactions for diversity-oriented synthesis", "volume": "14", "author": "Biggs-Houck", "year": "2010", "journal-title": "Curr. Opin. Chem. Biol."}, {"key": "10.1002/9781118771723.ch6-BIB126|cit161", "doi-asserted-by": "crossref", "first-page": "6234", "DOI": "10.1002/anie.201006515", "article-title": "Multicomponent reaction design in the quest for molecular complexity and diversity", "volume": "50", "author": "Ruijter", "year": "2011", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB127|cit162", "doi-asserted-by": "crossref", "first-page": "666", "DOI": "10.1055/s-0032-1318222", "article-title": "Efficiency, diversity, and complexity with multicomponent reactions", "volume": "24", "author": "Van", "year": "2013", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB128|cit163", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1021/cr8002714", "article-title": "Cyclic anhydrides in formal cycloadditions and multicomponent reactions", "volume": "109", "author": "Gonzalez-Lopez", "year": "2009", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB129|cit164", "doi-asserted-by": "crossref", "first-page": "3187", "DOI": "10.1021/jo01262a081", "article-title": "Condensation of succinic anhydride with N-benzylidene-N-methylamine. Stereoselective synthesis of trans- and cis-1-methyl-4-carboxy-5-phenyl-2-pyrrolidinone", "volume": "34", "author": "Castagnoli", "year": "1969", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB130|cit165", "doi-asserted-by": "crossref", "first-page": "1805", "DOI": "10.1016/S0040-4020(03)00076-0", "article-title": "Room temperature ionic liquids promoted three-component coupling reactions: a facile synthesis of cis-isoquinolonic acids", "volume": "59", "author": "Yadav", "year": "2003", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB131|cit166", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1002/adsc.200404211", "article-title": "One-pot synthesis of cis-isoquinolonic acid derivatives via three-component reaction of homophthalic anhydride with aldehydes and amines using ytterbium(III) triflate as catalyst", "volume": "347", "author": "Wang", "year": "2005", "journal-title": "Adv. Synth. Catal."}, {"key": "10.1002/9781118771723.ch6-BIB132|cit167", "doi-asserted-by": "crossref", "first-page": "4077", "DOI": "10.1021/ol701911u", "article-title": "Diastereoselective synthesis of \u03b3-lactams by a one-pot, four-component reaction", "volume": "9", "author": "Wei", "year": "2007", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB133|cit168", "doi-asserted-by": "crossref", "first-page": "5474", "DOI": "10.1039/b809206k", "article-title": "1-Azadienes in cycloaddition and multicomponent reactions towards N-heterocycles", "volume": "43", "author": "Groenendaal", "year": "2008", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB134|cit169", "doi-asserted-by": "crossref", "first-page": "9297", "DOI": "10.1016/0040-4039(95)02006-B", "article-title": "Reaction of in-situ generated \u03b1,\u03b2-unsaturated imines with CH-nucleophiles: a novel and efficient synthesis of pyridines", "volume": "36", "author": "Kiselyov", "year": "1995", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB135|cit170", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1021/ar800214s", "article-title": "Strategies for innovation in multicomponent reaction design", "volume": "42", "author": "Ganem", "year": "2009", "journal-title": "Acc. Chem. Res."}, {"key": "10.1002/9781118771723.ch6-BIB136|cit171", "doi-asserted-by": "crossref", "first-page": "1663", "DOI": "10.1016/j.tetlet.2005.01.068", "article-title": "One-pot synthesis of polysubstituted pyrimidines", "volume": "46", "author": "Kiselyov", "year": "2005", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB137|cit172", "doi-asserted-by": "crossref", "first-page": "2594", "DOI": "10.1039/b308243a", "article-title": "A novel four-component reaction for the synthesis of functionalized dihydropyrimidines", "volume": "20", "author": "Vugts", "year": "2003", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB138|cit173", "doi-asserted-by": "crossref", "first-page": "7178", "DOI": "10.1002/chem.200600168", "article-title": "Multicomponent synthesis of dihydropyrimidines and thiazines", "volume": "12", "author": "Vugts", "year": "2006", "journal-title": "Chem. Eur. J."}, {"key": "10.1002/9781118771723.ch6-BIB139|cit174", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1002/qsar.200540210", "article-title": "Microwave-assisted dimroth rearrangement of thiazines to dihydropyrimidinethiones: synthetic and mechanistic aspects", "volume": "25", "author": "Glasnov", "year": "2006", "journal-title": "QSAR Comb. Sci."}, {"key": "10.1002/9781118771723.ch6-BIB140|cit175", "doi-asserted-by": "crossref", "first-page": "5369", "DOI": "10.1021/ol062204b", "article-title": "Diastereoselective multicomponent synthesis of dihydropyridones with an isocyanide functionality", "volume": "8", "author": "Paravidino", "year": "2006", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB141|cit176", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.3390/molecules17021675", "article-title": "Multicomponent Synthesis of 3,6-Dihydro-2H-1,3-thiazine-2-thiones", "volume": "17", "author": "Kruithof", "year": "2012", "journal-title": "Molecules"}, {"key": "10.1002/9781118771723.ch6-BIB142|cit177", "doi-asserted-by": "crossref", "first-page": "2153", "DOI": "10.1016/j.tet.2008.12.002", "article-title": "Beyond the Ugi reaction: less conventional interactions between isocyanides and iminium species", "volume": "65", "author": "El Kaim", "year": "2009", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB143|cit178", "doi-asserted-by": "crossref", "first-page": "7961", "DOI": "10.1002/anie.200502636", "article-title": "Phenol ugi-smiles systems: strategies for the multicomponent N-arylation of primary amines with isocyanides, aldehydes, and phenols", "volume": "44", "author": "El Kaim", "year": "2005", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB143.2|cit179", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1007/s11030-009-9175-3", "article-title": "Ugi-Smiles couplings: new entries to N-aryl carboxamide derivatives", "volume": "14", "author": "El Kaim", "year": "2010", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB144|cit180", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.3987/COM-07-S(U)26", "article-title": "Ugi-Smiles access to quinoxalines derivatives", "volume": "73", "author": "Oble", "year": "2007", "journal-title": "Heterocycles"}, {"key": "10.1002/9781118771723.ch6-BIB145|cit181", "doi-asserted-by": "crossref", "first-page": "995", "DOI": "10.1021/ol8029438", "article-title": "New benzotriazole and benzimidazole scaffolds from Ugi-Smiles couplings of isocyanides", "volume": "11", "author": "El Kaim", "year": "2009", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB146|cit182", "doi-asserted-by": "crossref", "first-page": "3417", "DOI": "10.1021/ol801217a", "article-title": "New MCR-Heck-isomerization cascade towards indole", "volume": "10", "author": "El Kaim", "year": "2008", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB147|cit183", "doi-asserted-by": "crossref", "first-page": "5835", "DOI": "10.1021/jo070706c", "article-title": "New Ugi-Smiles-metathesis strategy towards the synthesis of pyrimido-azepines", "volume": "72", "author": "El Kaim", "year": "2007", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB148|cit184", "doi-asserted-by": "crossref", "first-page": "3622", "DOI": "10.1002/anie.200800494", "article-title": "Catalytic three-component Ugi reaction", "volume": "47", "author": "Pan", "year": "2008", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB149|cit185", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1007/s11030-009-9126-z", "article-title": "A novel three-component reaction for the synthesis of 3-aryl-4H-benzo [1,4] oxazin-2-amine", "volume": "13", "author": "Heravi", "year": "2009", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB150|cit186", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/j.molcata.2012.04.002", "article-title": "Cellulose-SO3H as a biodegradable solid acid catalyzed one-pot three-component Ugi reaction: synthesis of \u03b1-amino amide, 3,4-dihydroquinoxalin-2-amine, 4H-benzo[b][1,4]thiazin-2-amine and 1,6-dihydropyrazine-2,3-dicarbonitrile derivatives", "volume": "360", "author": "Mofakham", "year": "2012", "journal-title": "J. Mol. Cat. A: Chem."}, {"key": "10.1002/9781118771723.ch6-BIB151|cit187", "doi-asserted-by": "crossref", "first-page": "10280", "DOI": "10.1002/anie.201205366", "article-title": "Efficient assembly of iminodicarboxamides by a \u201ctruly\u201d\ufe01 four-component reaction", "volume": "51", "author": "Khoury", "year": "2012", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB151.2|cit188", "doi-asserted-by": "crossref", "first-page": "4792", "DOI": "10.1039/c3ob40523k", "article-title": "Various cyclization scaffolds by a truly Ugi 4-CR", "volume": "11", "author": "Sinha", "year": "2013", "journal-title": "Org. Biomol. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB152|cit189", "doi-asserted-by": "crossref", "first-page": "7279", "DOI": "10.1002/anie.201201905", "article-title": "A catalytic asymmetric Ugi-type reaction with acyclic azomethine imines", "volume": "51", "author": "Hashimoto", "year": "2012", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB153|cit190", "doi-asserted-by": "crossref", "first-page": "6735", "DOI": "10.1021/jo401131p", "article-title": "Multicomponent synthesis of 4-aminophthalazin-1(2H)-ones by palladium-catalyzed isocyanide insertion", "volume": "78", "author": "Vlaar", "year": "2013", "journal-title": "J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB154|cit191", "doi-asserted-by": "crossref", "first-page": "4708", "DOI": "10.1021/ja401701x", "article-title": "Synthesis of substituted pyridines from cascade [1+5] cycloaddition of isonitriles to N-formylmethyl-substituted enamides, aerobic oxidative aromatization, and acyl transfer reaction", "volume": "135", "author": "Lei", "year": "2013", "journal-title": "J. Am. Chem. Soc."}, {"key": "10.1002/9781118771723.ch6-BIB155|cit192", "doi-asserted-by": "crossref", "first-page": "7194", "DOI": "10.1002/anie.201302659", "article-title": "Three-component metal-free arylation of isocyanides", "volume": "52", "author": "Basavanag", "year": "2013", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB156|cit193", "doi-asserted-by": "crossref", "first-page": "2096", "DOI": "10.1002/anie.201209399", "article-title": "Ketene three-component reaction: a metal-free multicomponent approach to stereodefined captodative olefins", "volume": "52", "author": "Basso", "year": "2013", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB157|cit194", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1038/nchembio.758", "article-title": "Natural product-inspired cascade synthesis yields modulators of centrosome integrity", "volume": "8", "author": "D\u00fcckert", "year": "2012", "journal-title": "Nat. Chem. Biol."}, {"key": "10.1002/9781118771723.ch6-BIB158|cit195", "doi-asserted-by": "crossref", "first-page": "6719", "DOI": "10.1016/j.tetlet.2013.09.113", "article-title": "A simple one-pot 2-step N-1-alkylation of indoles with \u03b1-iminoketones toward the expeditious 3-step synthesis of N-1-quinoxaline-indoles", "volume": "54", "author": "Martinez-Ariza", "year": "2013", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB158.2|cit196", "unstructured": "McCall , J. M. John , R. Donnal , L. Clair , M. 2011 Heterocyclic compounds for the inhibition of PASK"}, {"key": "10.1002/9781118771723.ch6-BIB159|cit197", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1021/ar990006x", "article-title": "Organic synthesis and chemical ecology", "volume": "33", "author": "Mori", "year": "2000", "journal-title": "Acc. Chem. Res."}, {"key": "10.1002/9781118771723.ch6-BIB159.2|cit198", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0957-4166(02)00713-9", "article-title": "Enantioselective perception of chiral odorants", "volume": "14", "author": "Brenna", "year": "2003", "journal-title": "Tetrahedron Asymmetry"}, {"key": "10.1002/9781118771723.ch6-BIB159.3|cit199", "doi-asserted-by": "crossref", "first-page": "6752", "DOI": "10.1021/jm901241e", "article-title": "Escape from flatland: increasing saturation as an approach to improving clinical success", "volume": "52", "author": "Lovering", "year": "2009", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB159.4|cit200", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1039/c2md20347b", "article-title": "Escape from flatland 2: complexity and promiscuity", "volume": "4", "author": "Lovering", "year": "2013", "journal-title": "Med. Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB160|cit201", "doi-asserted-by": "crossref", "first-page": "3969", "DOI": "10.1039/c2cs15361k", "article-title": "Recent developments in asymmetric multicomponent reactions", "volume": "41", "author": "De Graaff", "year": "2012", "journal-title": "Chem. Soc. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB160.2|cit202", "doi-asserted-by": "crossref", "first-page": "1602", "DOI": "10.1002/anie.200460548", "article-title": "Asymmetric multicomponent reactions (AMCRs): the new frontier", "volume": "44", "author": "Ram\u00f3n", "year": "2005", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB161|cit203", "unstructured": "Znabet , A. 2012 Biocatalysis and multicomponent reactions: the ideal synergy. Asymmetric synthesis of substituted proline derivatives"}, {"key": "10.1002/9781118771723.ch6-BIB161.2|cit204", "doi-asserted-by": "crossref", "first-page": "3347", "DOI": "10.1002/adsc.201200254", "article-title": "Recent developments in enantioselective metal-catalyzed Domino reactions", "volume": "354", "author": "Clavier", "year": "2012", "journal-title": "Adv. Synth. Catal."}, {"key": "10.1002/9781118771723.ch6-BIB161.3|cit205", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/j.tetasy.2007.03.002", "article-title": "Organocatalytic enantioselective multicomponent reactions (OEMCRs)", "volume": "18", "author": "Guillena", "year": "2007", "journal-title": "Tetrahedron Asymmetry"}, {"key": "10.1002/9781118771723.ch6-BIB162|cit206", "doi-asserted-by": "crossref", "first-page": "6947", "DOI": "10.1021/cr200057t", "article-title": "Asymmetric Strecker reactions", "volume": "111", "author": "Wang", "year": "2011", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB163|cit207", "unstructured": "Xiao-Hua , C. Xie , B. 2013 Recent advances on organocatalysed asymmetric Mannich reactions Arkivoc 264 293", "DOI": "10.3998/ark.5550190.p007.839", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB163.2|cit208", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.5155/eurjchem.3.2.258-266.536", "article-title": "Recent progress in the asymmetric Mannich reaction", "volume": "3", "author": "Xiao-Hua", "year": "2012", "journal-title": "Eur. J. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB164|cit209", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1007/s11030-013-9439-9", "article-title": "Recent progress in asymmetric Biginelli reaction", "volume": "17", "author": "Heravi", "year": "2013", "journal-title": "Mol. Divers."}, {"key": "10.1002/9781118771723.ch6-BIB165|cit210", "doi-asserted-by": "crossref", "first-page": "6169", "DOI": "10.1021/cr100108k", "article-title": "Boronic acids and esters in the Petasis-borono mannich multicomponent reaction", "volume": "110", "author": "Candeias", "year": "2010", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB166|cit211", "doi-asserted-by": "crossref", "first-page": "9763", "DOI": "10.1039/c2ra21406g", "article-title": "Recent advances in new multicomponent synthesis of structurally diversified 1,4-dihydropyridines", "volume": "2", "author": "Jie-Ping", "year": "2012", "journal-title": "RSC Adv."}, {"key": "10.1002/9781118771723.ch6-BIB167|cit212", "doi-asserted-by": "crossref", "first-page": "2178", "DOI": "10.1039/b903816g", "article-title": "Organocatalysis-after the gold rush", "volume": "38", "author": "Bertelsen", "year": "2009", "journal-title": "Chem. Soc. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB167.2|cit213", "doi-asserted-by": "crossref", "first-page": "1821", "DOI": "10.1039/c2gc35160a", "article-title": "Evolution of asymmetric organocatalysis: multi- and retrocatalysis", "volume": "14", "author": "Wende", "year": "2012", "journal-title": "Green Chem."}, {"key": "10.1002/9781118771723.ch6-BIB168|cit214", "first-page": "79", "article-title": "Modern strategies in organic catalysis: the advent and development of iminium activation", "volume": "39", "author": "Lelais", "year": "2006", "journal-title": "Aldrichimca Acta"}, {"key": "10.1002/9781118771723.ch6-BIB168.2|cit215", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1246/bcsj.81.785", "article-title": "Discovery and application of asymmetric reaction by multi-functional thioureas", "volume": "81", "author": "Miyabe", "year": "2008", "journal-title": "Bull. Chem. Soc. Jpn."}, {"key": "10.1002/9781118771723.ch6-BIB168.3|cit216", "doi-asserted-by": "crossref", "first-page": "1187", "DOI": "10.1039/b801793j", "article-title": "(Thio)urea organocatalysis-what can be learnt from anion recognition?", "volume": "38", "author": "Zhang", "year": "2009", "journal-title": "Chem. Soc. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB168.4|cit217", "doi-asserted-by": "crossref", "first-page": "4144", "DOI": "10.2174/138527211798109231", "article-title": "Asymmetric organocatalytic cascade reactions catalyzed by chiral bronsted acids", "volume": "15", "author": "Peng", "year": "2011", "journal-title": "Curr. Org. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB168.5|cit218", "doi-asserted-by": "crossref", "first-page": "5606", "DOI": "10.1021/cr068372z", "article-title": "Organocatalysis by N-heterocyclic carbenes", "volume": "107", "author": "Enders", "year": "2007", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB168.6|cit219", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1126/science. 1142696", "article-title": "Enantioselective organocatalysis using SOMO activation", "volume": "316", "author": "Beeson", "year": "2007", "journal-title": "Science"}, {"key": "10.1002/9781118771723.ch6-BIB168.7|cit220", "doi-asserted-by": "crossref", "first-page": "3016", "DOI": "10.1039/b806418k", "article-title": "Controlling the formation of 1 out of 64 stereoisomers using organocatalysis", "volume": "26", "author": "Bertelsen", "year": "2008", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB169|cit221", "doi-asserted-by": "crossref", "first-page": "4231", "DOI": "10.1021/ol0482893", "article-title": "Stereochemical control of the Passerini reaction", "volume": "6", "author": "Andreana", "year": "2004", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB169.2|cit222", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.1002/anie.200704315", "article-title": "Catalytic enantioselective Passerini three-component reaction", "volume": "47", "author": "Wang", "year": "2008", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB170|cit223", "doi-asserted-by": "crossref", "first-page": "6717", "DOI": "10.1002/anie.200902385", "article-title": "Br\u00f8nsted acid catalyzed enantioselective three-component reaction involving the \u03b1-addition of isocyanides to imines", "volume": "48", "author": "Yue", "year": "2009", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB171|cit224", "doi-asserted-by": "crossref", "first-page": "3083", "DOI": "10.1021/cr100233r", "article-title": "Chemistry and biology of multicomponent reactions", "volume": "112", "author": "D\u00f6mling", "year": "2013", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB171.2|cit225", "doi-asserted-by": "crossref", "first-page": "1189", "DOI": "10.1039/c2md20089a", "article-title": "Recent applications of multicomponent reactions in medicinal chemistry", "volume": "3", "author": "Slobbe", "year": "2013", "journal-title": "Med. Chem. Comm."}, {"key": "10.1002/9781118771723.ch6-BIB171.3|cit226", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1016/j.cbpa.2008.02.004", "article-title": "Isocyanide-based multicomponent reactions in drug discovery", "volume": "12", "author": "Akritopoulou-Zanze", "year": "2008", "journal-title": "Curr. Opin. Chem. Biol."}, {"key": "10.1002/9781118771723.ch6-BIB172|cit227", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1038/nrd2907", "article-title": "Cell cycle kinases as therapeutic targets for cancer", "volume": "8", "author": "Lapenna", "year": "2009", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10.1002/9781118771723.ch6-BIB172.2|cit228", "doi-asserted-by": "crossref", "first-page": "2271", "DOI": "10.1021/cr000230w", "article-title": "Kinetic and catalytic mechanism of protein kinases", "volume": "101", "author": "Adams", "year": "2001", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB172.3|cit229", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/j.bbapap.2003.11.028", "article-title": "Kinomics-structural biology and chemogenomics of kinase inhibitors and targets", "volume": "1697", "author": "Vieth", "year": "2004", "journal-title": "Biochim. Biophys. Acta, Proteins Proteomics"}, {"key": "10.1002/9781118771723.ch6-BIB173|cit230", "doi-asserted-by": "crossref", "first-page": "1349", "DOI": "10.1351/pac200274081349", "article-title": "Development of a general process for the synthesis of highly substituted imidazoles", "volume": "74", "author": "Sisko", "year": "2002", "journal-title": "Pure Appl. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB173.2|cit231", "doi-asserted-by": "crossref", "first-page": "1117", "DOI": "10.1016/S0969-2126(98)00113-0", "article-title": "Structural basis of inhibitor selectivity in MAP kinases", "volume": "6", "author": "Wang", "year": "1998", "journal-title": "Structure"}, {"key": "10.1002/9781118771723.ch6-BIB174|cit232", "doi-asserted-by": "crossref", "first-page": "11311", "DOI": "10.1016/j.tet.2006.07.008", "article-title": "New conditions for the synthesis of thiophenes via the Knoevenagel-Gewald reaction sequence. Application to the synthesis of a multitargeted kinase inhibitors", "volume": "62", "author": "Barnes", "year": "2006", "journal-title": "Tetrahedron"}, {"key": "10.1002/9781118771723.ch6-BIB174.2|cit233", "doi-asserted-by": "crossref", "first-page": "6066", "DOI": "10.1021/jm050458h", "article-title": "Thienopyrimidines ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors", "volume": "48", "author": "Dai", "year": "2005", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB175|cit234", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1038/nrc2806", "article-title": "Eph receptors and ephrins in cancer: bidirectional signaling and beyond", "volume": "10", "author": "Pasquale", "year": "2010", "journal-title": "Nat. Rev. Cancer"}, {"key": "10.1002/9781118771723.ch6-BIB175.2|cit235", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1002/prot.22028", "article-title": "Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors", "volume": "73", "author": "Kolb", "year": "2008", "journal-title": "Proteins: Struct., Funct., Bioinf."}, {"key": "10.1002/9781118771723.ch6-BIB176|cit236", "doi-asserted-by": "crossref", "first-page": "982", "DOI": "10.1021/cc070058a", "article-title": "One-pot synthesis of quinoline-based tetracycles by a tandem three-component reaction", "volume": "9", "author": "Che", "year": "2007", "journal-title": "J. Comb. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB177|cit237", "unstructured": "Nixey , T. Boylan , J. Hulme , C. Powers , D. Smith , A. Wong , A. 2006 Inhibitors of the polo-like protein kinase Plk-1"}, {"key": "10.1002/9781118771723.ch6-BIB178|cit238", "first-page": "197", "article-title": "Binding of N2-substituted pyrido[4,3-b]indole analogues of spiperone at human 5-HT2A, 5-HT2B, and 5-HT2C serotonin receptors", "volume": "6", "author": "Ismaiel", "year": "1996", "journal-title": "Med. Chem. Res."}, {"key": "10.1002/9781118771723.ch6-BIB178.2|cit239", "doi-asserted-by": "crossref", "first-page": "5084", "DOI": "10.1021/jm980452a", "article-title": "Spiperone: influence of spiro-ring substituents on 5-HT2A serotonin receptor binding", "volume": "41", "author": "Metwally", "year": "1998", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB179|cit240", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1016/S1359-6446(01)01793-7", "article-title": "A genome perspective on human proteases as drug targets", "volume": "6", "author": "Southan", "year": "2001", "journal-title": "Drug Discov. Today"}, {"key": "10.1002/9781118771723.ch6-BIB179.2|cit241", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1038/nrd2092", "article-title": "Targeting proteases: success, failure and future prospects", "volume": "5", "author": "Turk", "year": "2006", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10.1002/9781118771723.ch6-BIB180|cit242", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1039/b002027n", "article-title": "Passerini multicomponent reaction of protected \u03b1-aminoaldehydes as a tool for combinatorial synthesis of enzyme inhibitors", "volume": "2000", "author": "Banfi", "year": "2000", "journal-title": "Chem. Commun."}, {"key": "10.1002/9781118771723.ch6-BIB180.2|cit243", "doi-asserted-by": "crossref", "first-page": "2769", "DOI": "10.1021/ol0061485", "article-title": "New synthetic technology for efficient construction of \u03b1-hydroxy-\u03b2-amino amides via the Passerini reaction", "volume": "2", "author": "Semple", "year": "2000", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB180.3|cit244", "doi-asserted-by": "crossref", "first-page": "4067", "DOI": "10.1016/S0040-4039(02)00728-1", "article-title": "Short synthesis of protease inhibitors via modified Passerini condensation of N-Boc-\u03b1-aminoaldehydes", "volume": "43", "author": "Banfi", "year": "2002", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB181|cit245", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1021/jm801201u", "article-title": "Design, synthesis and evaluation of oxygen-containing macrocyclic peptidomimetics as inhibitors of HCV NS3 protease", "volume": "52", "author": "Vel\u00e1zquez", "year": "2009", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB181.2|cit246", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1021/jm800940u", "article-title": "Discovery and structure-activity relationships of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease", "volume": "52", "author": "Venkatraman", "year": "2008", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB181.3|cit247", "doi-asserted-by": "crossref", "first-page": "3061", "DOI": "10.1021/ol0711265", "article-title": "Application of ring-closing metathesis for the synthesis of macrocyclic peptidomimetics as inhibitors of NCV NS3 proteases", "volume": "9", "author": "Velazquez", "year": "2007", "journal-title": "Org. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB181.4|cit248", "doi-asserted-by": "crossref", "first-page": "2310", "DOI": "10.1021/jm060173k", "article-title": "Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N- [3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3[2(S)[[[(1,1dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide(Sch 503034) II. Key steps in structure-based optimization", "volume": "50", "author": "Prongay", "year": "2007", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB182|cit249", "doi-asserted-by": "crossref", "first-page": "6833", "DOI": "10.1016/S0040-4039(02)01505-8", "article-title": "Rapid generation of cis-constrained norstatine analogs using TMSN3-modified Passerini MCC-N capping strategy", "volume": "43", "author": "Nixey", "year": "2002", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB183|cit250", "doi-asserted-by": "crossref", "first-page": "1206", "DOI": "10.1107/S0907444903010059", "article-title": "High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[({2-[(5-iodopyridin-2-yl)amino]-ethyl}amino)-acetyl]-2-cyano-(S)-pyrrolidine)", "volume": "59", "author": "Oefner", "year": "2003", "journal-title": "Acta Crystallogr. D Biol. Crystallogr."}, {"key": "10.1002/9781118771723.ch6-BIB183.2|cit251", "doi-asserted-by": "crossref", "first-page": "688", "DOI": "10.1055/s-2004-817764", "article-title": "Substituted 2-(cyanomethyl-amino)-amides via a novel three component reaction", "volume": "2004", "author": "Behnke", "year": "2004", "journal-title": "Synlett"}, {"key": "10.1002/9781118771723.ch6-BIB183.3|cit252", "doi-asserted-by": "crossref", "first-page": "6096", "DOI": "10.1002/chem.200900785", "article-title": "A multicomponent reaction towards N-(Cyanomethyl)amides", "volume": "15", "author": "Elders", "year": "2009", "journal-title": "Chem. Eur. J."}, {"key": "10.1002/9781118771723.ch6-BIB184|cit253", "doi-asserted-by": "crossref", "first-page": "6823", "DOI": "10.1016/S0040-4039(98)01484-1", "article-title": "An efficient asymmetric hydrogenation approach to the synthesis of Crixivan piperazine intermediate", "volume": "39", "author": "Rossen", "year": "1998", "journal-title": "Tetrahedron Lett."}, {"key": "10.1002/9781118771723.ch6-BIB185|cit254", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1038/nrd821", "article-title": "Novel animal-health drug targets from ligand-gated chloride channels", "volume": "1", "author": "Raymond", "year": "2002", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10.1002/9781118771723.ch6-BIB185.2|cit255", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1038/nature08198", "article-title": "Crystal structure of the ATP gated P2X4 ion channel in the close state", "volume": "460", "author": "Kawate", "year": "2009", "journal-title": "Nature"}, {"key": "10.1002/9781118771723.ch6-BIB186|cit256", "doi-asserted-by": "crossref", "first-page": "1559", "DOI": "10.1002/anie.199115591", "article-title": "1,4-dihydropyridines: effects of chirality and conformation on the calcium antagonist and calcium agonist activities", "volume": "30", "author": "Goldmann", "year": "1991", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "10.1002/9781118771723.ch6-BIB187|cit257", "unstructured": "Ugi , I. Steinbrueckner , C. 1961 Aktiebolaget Astra Apotekarnes Kemiska Fabriker"}, {"key": "10.1002/9781118771723.ch6-BIB188|cit258", "doi-asserted-by": "crossref", "first-page": "6381", "DOI": "10.1016/j.bmcl.2008.10.099", "article-title": "Dihydropyrazolopyrimidines inhibitors of Kv 1.5 (Ikur)", "volume": "18", "author": "Vaccaro", "year": "2008", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB188.2|cit259", "doi-asserted-by": "crossref", "first-page": "5469", "DOI": "10.1016/j.bmcl.2009.07.083", "article-title": "Dihydropyrazolopyrimidines containing benzimidazoles as Kv 1.5 potassium channel antagonists", "volume": "19", "author": "Lloyd", "year": "2009", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB189|cit260", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1038/nrd1343", "article-title": "Small-molecule inhibitors of protein-protein interactions: progressing towards the dream", "volume": "3", "author": "Arkin", "year": "2004", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10.1002/9781118771723.ch6-BIB189.2|cit261", "author": "Jacoby", "year": "2009", "volume-title": "Chemogenomics: Methods and Applications", "DOI": "10.1007/978-1-60761-274-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118771723.ch6-BIB189.3|cit262", "doi-asserted-by": "crossref", "first-page": "e1000695", "DOI": "10.1371/journal.pcbi.1000695", "article-title": "Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods", "volume": "6", "author": "Reyn\u00e8s", "year": "2010", "journal-title": "PLoS Comput. Biol."}, {"key": "10.1002/9781118771723.ch6-BIB190|cit263", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1158/1541-7786.MCR-08-0423", "article-title": "Targeting mdm2 and mdmx in cancer therapy: better living through medicinal chemistry?", "volume": "7", "author": "Wade", "year": "2009", "journal-title": "Mol. Cancer Res."}, {"key": "10.1002/9781118771723.ch6-BIB191|cit264", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1021/jm049137g", "article-title": "Discovery and cocrystal structure of benzodiazepinedione HMD2 antagonists that activate p53 in cells", "volume": "48", "author": "Grasberger", "year": "2005", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB191.2|cit265", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1016/j.bmcl.2004.11.009", "article-title": "1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR", "volume": "15", "author": "Parks", "year": "2005", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB191.3|cit266", "doi-asserted-by": "crossref", "first-page": "3115", "DOI": "10.1016/j.bmcl.2006.03.067", "article-title": "Enantiomerically pure 1,4-benzodiazepine-2,5-diones as HDM2 antagonists", "volume": "16", "author": "Marugan", "year": "2006", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB191.4|cit267", "doi-asserted-by": "crossref", "first-page": "3310", "DOI": "10.1016/j.bmcl.2006.03.055", "article-title": "Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design", "volume": "16", "author": "Parks", "year": "2006", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB192|cit268", "unstructured": "Burdack , C. Kalinsky , C. Ross , G. Weber , L. Khazak , V. 2010 Pyrrolidin-2-ones as hdm2 ligands"}, {"key": "10.1002/9781118771723.ch6-BIB193|cit269", "doi-asserted-by": "crossref", "first-page": "790", "DOI": "10.1038/nrd3253", "article-title": "Microtubule-binding agents: a dynamic field of cancer therapeutics", "volume": "9", "author": "Dumontet", "year": "2010", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10.1002/9781118771723.ch6-BIB194|cit270", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.7164/antibiotics.53.879", "article-title": "Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties", "volume": "53", "author": "Sasse", "year": "2000", "journal-title": "J. Antibiot."}, {"key": "10.1002/9781118771723.ch6-BIB195|cit271", "doi-asserted-by": "crossref", "first-page": "7692", "DOI": "10.1021/ja2022027", "article-title": "The multiple multicomponent approach to natural product mimics: tubugis, N-substituted anticancer peptides with picomolar activity", "volume": "133", "author": "Pando", "year": "2011", "journal-title": "J. Am. Chem. Soc."}, {"key": "10.1002/9781118771723.ch6-BIB196|cit272", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.2174/092986709787002682", "article-title": "A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007", "volume": "16", "author": "Xu", "year": "2009", "journal-title": "Curr. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB197|cit273", "doi-asserted-by": "crossref", "first-page": "5183", "DOI": "10.1021/jm070528f", "article-title": "Discovery and investigation of antiproliferative and apoptosis-Inducing properties of new heterocyclic Podophyllotoxin analogues accessible by a one-step multicomponent synthesis", "volume": "50", "author": "Magedov", "year": "2007", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB198|cit274", "doi-asserted-by": "crossref", "first-page": "4234", "DOI": "10.1021/jm200410r", "article-title": "Anticancer properties of an important drug lead Podophyllotoxin can be efficiently mimicked by diverse heterocyclic scaffolds accessible via one-step synthesis", "volume": "54", "author": "Magedov", "year": "2011", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB198.2|cit275", "doi-asserted-by": "crossref", "first-page": "3872", "DOI": "10.1016/j.bmcl.2007.05.004", "article-title": "Antiproliferative and apoptosis inducing properties of pyrano[3,2-c]pyridones accessible by a one-step multicomponent synthesis", "volume": "17", "author": "Magedov", "year": "2007", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB199|cit276", "doi-asserted-by": "crossref", "first-page": "2561", "DOI": "10.1021/jm701499n", "article-title": "Structural simplification of bioactive natural products with multicomponent synthesis. 2. Antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones", "volume": "51", "author": "Magedov", "year": "2008", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB200|cit277", "doi-asserted-by": "crossref", "first-page": "2012", "DOI": "10.1021/jm1009428", "article-title": "Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents", "volume": "54", "author": "Evdokimov", "year": "2011", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB201|cit278", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.1016/S0960-894X(99)00143-2", "article-title": "A new anti-tubulin agent containing the benzo[b]thiophene ring system", "volume": "9", "author": "Pinney", "year": "1999", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB202|cit279", "doi-asserted-by": "crossref", "first-page": "6014", "DOI": "10.1021/jm200454y", "article-title": "Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties", "volume": "54", "author": "Flynn", "year": "2011", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB203|cit280", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1021/cr040689g", "article-title": "Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure", "volume": "105", "author": "Tyndall", "year": "2005", "journal-title": "Chem. Rev."}, {"key": "10.1002/9781118771723.ch6-BIB204|cit281", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.1002/cmdc.200600134", "article-title": "The 7-TM G-protein-coupled receptor target family", "volume": "1", "author": "Jacoby", "year": "2006", "journal-title": "ChemMedChem."}, {"key": "10.1002/9781118771723.ch6-BIB205|cit282", "doi-asserted-by": "crossref", "first-page": "4140", "DOI": "10.1021/jm060051s", "article-title": "Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists", "volume": "49", "author": "Habashita", "year": "2006", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB205.2|cit283", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1016/j.bmcl.2006.10.084", "article-title": "Spirodiketopiperazine-based CCR5 antagonists: lead optimization from biologically active metabolite", "volume": "17", "author": "Nishizawa", "year": "2007", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB206|cit284", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1021/jm801296d", "article-title": "Biomedical application of orexin/hypocretin receptor ligands in neuroscience", "volume": "52", "author": "Boss", "year": "2009", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB207|cit285", "doi-asserted-by": "crossref", "first-page": "1197", "DOI": "10.1002/cmdc.201000132", "article-title": "Orexin receptor antagonists: a new concept in CNS disorders?", "volume": "5", "author": "Gatfield", "year": "2010", "journal-title": "ChemMedChem"}, {"key": "10.1002/9781118771723.ch6-BIB208|cit286", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1038/nm1544", "article-title": "Promotion of sleep by targeting the orexin system in rats, dogs and humans", "volume": "13", "author": "Brisbare-Roch", "year": "2007", "journal-title": "Nat. Med."}, {"key": "10.1002/9781118771723.ch6-BIB209|cit287", "unstructured": "Aissaoui , H. Cappi , M. Clozel , M. Fischli , W. Koberstein , R. 2001 Preparation of 1,2,3,4-tetrahydroisoquinolines as orexin receptor antagonists"}, {"key": "10.1002/9781118771723.ch6-BIB210|cit288", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1677/joe.0.1610143", "article-title": "Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labor", "volume": "161", "author": "Wathes", "year": "1999", "journal-title": "J. Endocrinol."}, {"key": "10.1002/9781118771723.ch6-BIB211|cit289", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/j.bmcl.2007.11.008", "article-title": "The discovery of GSK221149A: a potent and selective oxytocin antagonist", "volume": "18", "author": "Liddle", "year": "2008", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB212|cit290", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1146/annurev.pharmtox.44.101802.121410", "article-title": "CRF and CRF receptors: role in stress responsivity and other behaviors", "volume": "44", "author": "Bale", "year": "2004", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10.1002/9781118771723.ch6-BIB213|cit291", "doi-asserted-by": "crossref", "first-page": "2426", "DOI": "10.1021/jm049974i", "article-title": "N-phenylphenylglycines as novel corticotropin releasing factor receptor antagonists", "volume": "47", "author": "Molteni", "year": "2004", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118771723.ch6-BIB214|cit292", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/S0165-6147(99)01432-7", "article-title": "5-HT7 receptors: current knowledge and future prospects", "volume": "21", "author": "Vanhoenacker", "year": "2000", "journal-title": "Trends Pharmacol. Sci."}, {"key": "10.1002/9781118771723.ch6-BIB215|cit293", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1016/j.bmcl.2010.11.078", "article-title": "Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT7 antagonists", "volume": "21", "author": "Rudolph", "year": "2011", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118771723.ch6-BIB216|cit294", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1007/s12031-010-9411-4", "article-title": "Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists", "volume": "43", "author": "Chung", "year": "2011", "journal-title": "J. Mol. Neurosci."}, {"key": "10.1002/9781118771723.ch6-BIB217|cit295", "doi-asserted-by": "crossref", "first-page": "7651", "DOI": "10.1021/jo801463j", "article-title": "Enantioselective synthesis of SNAP-7941: chiral dihydropyrimidone inhibitor of MCH1-R", "volume": "73", "author": "Goss", "year": "2008", "journal-title": "J. Org. Chem."}], "container-title": ["Small Molecule Medicinal Chemistry"], "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9781118771723.ch6", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 31]], "date-time": "2019-08-31T00:48:31Z", "timestamp": 1567212511000}, "score": 26.286163, "subtitle": ["Applications in Small Molecule Drug Discovery"], "issued": {"date-parts": [[2015, 9, 26]]}, "ISBN": ["9781118771723", "9781118771600"], "references-count": 295, "URL": "http://dx.doi.org/10.1002/9781118771723.ch6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:53:57Z", "timestamp": 1576799637792}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "6_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2017, 2, 20]]}, "abstract": "<jats:p> 170 </jats:p><jats:p> Background: PCWG2 radiographic progression criteria, which are associated with survival, rely on lesion counting. There is a need for a fully quantitative assessment of tumor burden as a component of a true response biomarker for mCRPC. Here, we used the bone scan index (BSI) to fully quantitate the increase in skeletal disease burden at each radiographic milestone that constitutes the PCWG2 criteria. Methods: mCRPC patients (pts) from clinical trials using PCWG2 criteria to determine progression (PD) were assessed. Pts were required to have baseline (BL) and at least two follow-up (FU) bone scans. The EXINI automated platform was used to generate BSI at key PCWG2 landmarks: 2+2 criteria for early PD and post flare PD criteria with the appearance of 1 and \u22652 new lesions. Median (M) and Interquartile range (IQR) of the relative change in BSI were calculated to quantify the increase in total tumor burden. Results: A total of 257 pts were assessed, of whom 169 had two or more FU bone scans at 8 or 12 week intervals. Of the total 169 pts, 86 (51%, 95%CI 43-58) met PD by PCWG criteria. 35 (41%, 95%CI 31-51) of 86 pts met the early PD criteria, the remaining 51 (59%, 95%CI 49-69) met PD at subsequent time points after flare period. The ability of the automated platform to reproduce a BSI value, retrieved from the same scan, was highly consistent (100%). The relative BSI increase during the course of meeting PD by PCWG2 is shown in the Table. Conclusions: This is the first quantitative assessment of changes in total tumor burden in pts meeting PCWG2 criteria. Relative changes in BSI can be substantial in meeting the criteria. These data build on the PCWG2 criteria by quantitating the increase both of existing lesions and the contribution of new lesions. We are now assessing the associations with survival that these incremental increases represent. [Table: see text] </jats:p>", "DOI": "10.1200/jco.2017.35.6_suppl.170", "type": "journal-article", "created": {"date-parts": [[2017, 3, 29]], "date-time": "2017-03-29T15:03:53Z", "timestamp": 1490799833000}, "page": "170-170", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Translating Prostate Cancer Working Group 2 (PCWG2) progression criteria into a quantitative response biomarker in metastatic castration-resistant prostate cancer (mCRPC)."], "prefix": "10.1200", "volume": "35", "author": [{"given": "Aseem", "family": "Anand", "sequence": "first", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center, New York, NY;"}]}, {"given": "Anders", "family": "Bjartell", "sequence": "additional", "affiliation": [{"name": "Skane University Hospital, Malmo, Sweden;"}]}, {"given": "Daniel Costin", "family": "Danila", "sequence": "additional", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center, New York, NY;"}]}, {"given": "Danny Francisco", "family": "Martinez", "sequence": "additional", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center, New York, NY;"}]}, {"given": "Lars", "family": "Edenbrandt", "sequence": "additional", "affiliation": [{"name": "Skane University Hospital, Malmo, Sweden;"}]}, {"given": "Steven M.", "family": "Larson", "sequence": "additional", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center, New York, NY;"}]}, {"given": "Howard I.", "family": "Scher", "sequence": "additional", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center, New York, NY;"}]}, {"given": "Michael J.", "family": "Morris", "sequence": "additional", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.35.6_suppl.170", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:14:46Z", "timestamp": 1574892886000}, "score": 25.746403, "issued": {"date-parts": [[2017, 2, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 2, 20]]}, "issue": "6_suppl"}, "alternative-id": ["10.1200/JCO.2017.35.6_suppl.170"], "URL": "http://dx.doi.org/10.1200/jco.2017.35.6_suppl.170", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T21:44:03Z", "timestamp": 1574718243034}, "reference-count": 27, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2016, 11, 16]], "date-time": "2016-11-16T00:00:00Z", "timestamp": 1479254400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2016, 11, 16]], "date-time": "2016-11-16T00:00:00Z", "timestamp": 1479254400000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"name": "Active Biotech", "award": []}, {"name": "US Department of Defense Prostate Cancer Clinical Trials Consortium", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2017, 3]]}, "DOI": "10.1002/pros.23277", "type": "journal-article", "created": {"date-parts": [[2016, 11, 16]], "date-time": "2016-11-16T19:38:24Z", "timestamp": 1479325104000}, "page": "385-395", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial"], "prefix": "10.1002", "volume": "77", "author": [{"given": "Andrew J.", "family": "Armstrong", "sequence": "first", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}, {"given": "Michael S.", "family": "Humeniuk", "sequence": "additional", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}, {"given": "Patrick", "family": "Healy", "sequence": "additional", "affiliation": [{"name": "Department of Biostatistics; Duke University; Durham North Carolina"}]}, {"given": "Russell", "family": "Szmulewitz", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; University of Chicago; Chicago Illinois"}]}, {"given": "Carolyn", "family": "Winters", "sequence": "additional", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}, {"given": "Julie", "family": "Kephart", "sequence": "additional", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}, {"given": "Michael R.", "family": "Harrison", "sequence": "additional", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}, {"given": "Elia", "family": "Martinez", "sequence": "additional", "affiliation": [{"name": "Department of Medicine; University of Chicago; Chicago Illinois"}]}, {"given": "Kelly", "family": "Mundy", "sequence": "additional", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}, {"given": "Susan", "family": "Halabi", "sequence": "additional", "affiliation": [{"name": "Department of Biostatistics; Duke University; Durham North Carolina"}]}, {"given": "Daniel", "family": "George", "sequence": "additional", "affiliation": [{"name": "Divisions of Medical Oncology and Urology; Departments of Medicine and Surgery; Duke Cancer Institute; Durham North Carolina"}]}], "member": "311", "published-online": {"date-parts": [[2016, 11, 16]]}, "reference": [{"key": "10.1002/pros.23277-BIB0001|pros23277-cit-0001", "doi-asserted-by": "crossref", "first-page": "1235", "DOI": "10.1517/13543784.2010.514262", "article-title": "The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer", "volume": "19", "author": "Isaacs", "year": "2010", "journal-title": "Expert Opin Investig Drugs"}, {"key": "10.1002/pros.23277-BIB0002|pros23277-cit-0002", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1177/1756287215603558", "article-title": "Tasquinimod in the treatment of castrate-resistant prostate cancer-Current status and future prospects", "volume": "8", "author": "Mehta", "year": "2016", "journal-title": "Ther Adv Urol"}, {"key": "10.1002/pros.23277-BIB0003|pros23277-cit-0003", "doi-asserted-by": "crossref", "first-page": "e97", "DOI": "10.1371/journal.pbio.1000097", "article-title": "Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides", "volume": "7", "author": "Bjork", "year": "2009", "journal-title": "PLoS Biol"}, {"key": "10.1002/pros.23277-BIB0004|pros23277-cit-0004", "doi-asserted-by": "crossref", "first-page": "2235", "DOI": "10.1084/jem.20080132", "article-title": "Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein", "volume": "205", "author": "Cheng", "year": "2008", "journal-title": "J Exp Med"}, {"key": "10.1002/pros.23277-BIB0005|pros23277-cit-0005", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1016/j.yexcr.2005.10.013", "article-title": "S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells", "volume": "312", "author": "Hermani", "year": "2006", "journal-title": "Exp Cell Res"}, {"key": "10.1002/pros.23277-BIB0006|pros23277-cit-0006", "doi-asserted-by": "crossref", "first-page": "354", "DOI": "10.1038/35012626", "article-title": "Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases", "volume": "405", "author": "Taguchi", "year": "2000", "journal-title": "Nature"}, {"key": "10.1002/pros.23277-BIB0007|pros23277-cit-0007", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1186/1476-4598-9-107", "article-title": "Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors", "volume": "9", "author": "Olsson", "year": "2010", "journal-title": "Mol Cancer"}, {"key": "10.1002/pros.23277-BIB0008|pros23277-cit-0008", "doi-asserted-by": "crossref", "first-page": "1386", "DOI": "10.1158/0008-5472.CAN-12-2730", "article-title": "Tasquinimod is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment", "volume": "73", "author": "Isaacs", "year": "2013", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.23277-BIB0009|pros23277-cit-0009", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1002/pros.23133", "article-title": "Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment", "volume": "76", "author": "Magnusson", "year": "2016", "journal-title": "Prostate"}, {"key": "10.1002/pros.23277-BIB0010|pros23277-cit-0010", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1002/pros.21495", "article-title": "Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)", "volume": "72", "author": "Jennbacken", "year": "2012", "journal-title": "Prostate"}, {"key": "10.1002/pros.23277-BIB0011|pros23277-cit-0011", "doi-asserted-by": "crossref", "first-page": "1233", "DOI": "10.1038/sj.bjc.6605322", "article-title": "Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer", "volume": "101", "author": "Bratt", "year": "2009", "journal-title": "Br J Cancer"}, {"key": "10.1002/pros.23277-BIB0012|pros23277-cit-0012", "doi-asserted-by": "crossref", "first-page": "4022", "DOI": "10.1200/JCO.2011.35.6295", "article-title": "Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer", "volume": "29", "author": "Pili", "year": "2011", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pros.23277-BIB0013|pros23277-cit-0013", "doi-asserted-by": "crossref", "first-page": "6891", "DOI": "10.1158/1078-0432.CCR-13-1581", "article-title": "Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer", "volume": "19", "author": "Armstrong", "year": "2013", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/pros.23277-BIB0014|pros23277-cit-0014", "doi-asserted-by": "crossref", "first-page": "1148", "DOI": "10.1200/JCO.2007.12.4487", "article-title": "Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group", "volume": "26", "author": "Scher", "year": "2008", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pros.23277-BIB0015|pros23277-cit-0015", "doi-asserted-by": "crossref", "first-page": "2636", "DOI": "10.1200/JCO.2016.66.9697", "article-title": "Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer", "volume": "34", "author": "Sternberg", "year": "2016", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pros.23277-BIB0016|pros23277-cit-0016", "doi-asserted-by": "crossref", "first-page": "790", "DOI": "10.1002/pros.20573", "article-title": "The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts", "volume": "67", "author": "Dalrymple", "year": "2007", "journal-title": "Prostate"}, {"key": "10.1002/pros.23277-BIB0017|pros23277-cit-0017", "doi-asserted-by": "crossref", "first-page": "1147", "DOI": "10.1016/S0140-6736(10)61389-X", "article-title": "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial", "volume": "376", "author": "de Bono", "year": "2010", "journal-title": "Lancet"}, {"key": "10.1002/pros.23277-BIB0018|pros23277-cit-0018", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1016/j.ejca.2008.10.026", "article-title": "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)", "volume": "45", "author": "Eisenhauer", "year": "2009", "journal-title": "Eur J Cancer"}, {"key": "10.1002/pros.23277-BIB0019|pros23277-cit-0019", "doi-asserted-by": "crossref", "first-page": "3401", "DOI": "10.1016/j.jchromb.2011.09.013", "article-title": "Bioanalysis in clinical development of tasquinimod using liquid chromatography/tandem mass spectrometry", "volume": "879", "author": "Hansson", "year": "2011", "journal-title": "J Chromatogr B Analyt Technol Biomed Life Sci"}, {"key": "10.1002/pros.23277-BIB0020|pros23277-cit-0020", "unstructured": "Sennbro CJ"}, {"key": "10.1002/pros.23277-BIB0021|pros23277-cit-0021", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1007/s00280-012-2058-9", "article-title": "Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors", "volume": "71", "author": "Ferron", "year": "2013", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "10.1002/pros.23277-BIB0022|pros23277-cit-0022", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1158/1078-0432.CCR-08-0596", "article-title": "Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors", "volume": "15", "author": "Mita", "year": "2009", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/pros.23277-BIB0023|pros23277-cit-0023", "doi-asserted-by": "crossref", "first-page": "790", "DOI": "10.1002/pros.20573", "article-title": "The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts", "volume": "67", "author": "Dalrymple", "year": "2007", "journal-title": "Prostate"}, {"key": "10.1002/pros.23277-BIB0024|pros23277-cit-0024", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1002/pros.21495", "article-title": "Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)", "volume": "72", "author": "Jennbacken", "year": "2012", "journal-title": "Prostate"}, {"key": "10.1002/pros.23277-BIB0025|pros23277-cit-0025", "doi-asserted-by": "crossref", "first-page": "4022", "DOI": "10.1200/JCO.2011.35.6295", "article-title": "Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer", "volume": "29", "author": "Pili", "year": "2011", "journal-title": "J ClinOncol"}, {"key": "10.1002/pros.23277-BIB0026|pros23277-cit-0026", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1002/pros.21467", "article-title": "Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts", "volume": "72", "author": "Dalrymple", "year": "2012", "journal-title": "Prostate"}, {"key": "10.1002/pros.23277-BIB0027|pros23277-cit-0027", "doi-asserted-by": "crossref", "first-page": "2636", "DOI": "10.1200/JCO.2016.66.9697", "article-title": "Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer", "volume": "34", "author": "Sternberg", "year": "2016", "journal-title": "J Clin Oncol"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23277", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/pros.23277", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 15]], "date-time": "2019-09-15T16:57:03Z", "timestamp": 1568566623000}, "score": 25.665756, "subtitle": ["Tasquinimod and Cabazitaxel in mCRPC"], "issued": {"date-parts": [[2016, 11, 16]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2017, 3]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/pros.23277", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T03:47:07Z", "timestamp": 1574826427784}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000, 7, 1]]}, "DOI": "10.21236/ada390712", "type": "report", "created": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T22:03:53Z", "timestamp": 1503612233000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Cell Cycle Regulation of Estrogen and Androgen Receptor"], "prefix": "10.21236", "author": [{"given": "Elisabeth D.", "family": "Martinez", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T22:03:53Z", "timestamp": 1503612233000}, "score": 25.564022, "subtitle": [""], "issued": {"date-parts": [[2000, 7, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada390712"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:26:57Z", "timestamp": 1574238417260}, "reference-count": 76, "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Cell Proteomics"], "published-print": {"date-parts": [[2007, 2]]}, "DOI": "10.1074/mcp.m600169-mcp200", "type": "journal-article", "created": {"date-parts": [[2006, 10, 20]], "date-time": "2006-10-20T00:33:03Z", "timestamp": 1161304383000}, "page": "252-271", "source": "Crossref", "is-referenced-by-count": 36, "title": ["Identification of Putative Androgen Receptor Interaction Protein Modules"], "prefix": "10.1074", "volume": "6", "author": [{"given": "Rohini", "family": "Jasavala", "sequence": "first", "affiliation": []}, {"given": "Harryl", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "Jaykumar", "family": "Thumar", "sequence": "additional", "affiliation": []}, {"given": "Armann", "family": "Andaya", "sequence": "additional", "affiliation": []}, {"given": "Anne-Claude", "family": "Gingras", "sequence": "additional", "affiliation": []}, {"given": "Jimmy K.", "family": "Eng", "sequence": "additional", "affiliation": []}, {"given": "Ruedi", "family": "Aebersold", "sequence": "additional", "affiliation": []}, {"given": "David K.", "family": "Han", "sequence": "additional", "affiliation": []}, {"given": "Michael E.", "family": "Wright", "sequence": "additional", "affiliation": []}], "member": "28", "published-online": {"date-parts": [[2006, 10, 18]]}, "reference": [{"key": "2017062701085530000_6.2.252.1", "DOI": "10.1200/JCO.2002.10.018", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.2", "DOI": "10.1016/S0083-6729(08)61152-8", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.3", "DOI": "10.1615/CritRevEukaryotGeneExpr.v12.i3.30", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.4", "DOI": "10.1210/me.7.1.4", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.5", "DOI": "10.1210/me.11.2.148", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.6", "volume": "228", "first-page": "111", "year": "2003", "journal-title": "Exp. Biol. Med.", "DOI": "10.1177/153537020322800201", "doi-asserted-by": "crossref"}, {"key": "2017062701085530000_6.2.252.7", "DOI": "10.1073/pnas.94.15.7879", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.8", "DOI": "10.1146/annurev.bi.63.070194.002315", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.9", "DOI": "10.1016/S0960-0760(00)00154-0", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.10", "DOI": "10.1210/me.6.12.2229", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.11", "DOI": "10.1210/er.23.2.175", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.12", "DOI": "10.1158/1078-0432.CCR-0746-3", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.13", "DOI": "10.1210/me.2003-0317", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.14", "DOI": "10.1210/me.2002-0070", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.15", "DOI": "10.1210/me.2003-0032", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.16", "DOI": "10.1038/35011540", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.17", "DOI": "10.1006/bbrc.1994.2118", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.18", "DOI": "10.1002/humu.20044", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.19", "DOI": "10.1074/mcp.M500231-MCP200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.20", "DOI": "10.1186/gb-2003-5-1-r4", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.21", "DOI": "10.1016/1044-0305(94)80016-2", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.22", "DOI": "10.1021/ac0341261", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.23", "volume": "74", "first-page": "5383", "year": "2002", "journal-title": "nal. Chem."}, {"key": "2017062701085530000_6.2.252.24", "DOI": "10.1038/nbt1001-946", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.25", "DOI": "10.1038/ng1101", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.26", "DOI": "10.1210/me.2003-0031", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.27", "DOI": "10.1074/jbc.C400046200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.28", "DOI": "10.1038/nature01511", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.29", "DOI": "10.1158/1078-0432.CCR-04-0388", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.30", "volume": "267", "first-page": "968", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2017062701085530000_6.2.252.31", "DOI": "10.1016/0022-4731(82)90117-0", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.32", "volume": "40", "first-page": "41", "year": "2004", "journal-title": "Essays Biochem.", "DOI": "10.1042/bse0400041", "doi-asserted-by": "crossref"}, {"key": "2017062701085530000_6.2.252.33", "DOI": "10.2174/1381612053507585", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.34", "DOI": "10.1021/bi0259150", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.35", "DOI": "10.1038/13690", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.36", "DOI": "10.1038/nsmb713", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.37", "DOI": "10.1006/meth.2001.1183", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.38", "DOI": "10.1038/75556", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.39", "DOI": "10.1101/gr.1239303", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.40", "DOI": "10.1093/bioinformatics/bti551", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.41", "DOI": "10.1101/gr.1680803", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.42", "DOI": "10.1093/emboj/cdg362", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.43", "DOI": "10.1073/pnas.0504166102", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.44", "DOI": "10.1074/jbc.M502203200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.45", "DOI": "10.1073/pnas.0307161101", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.46", "DOI": "10.1073/pnas.0736237100", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.47", "volume": "63", "first-page": "4888", "year": "2003", "journal-title": "Cancer Res."}, {"key": "2017062701085530000_6.2.252.48", "DOI": "10.1083/jcb.200211099", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.49", "DOI": "10.1016/j.steroids.2004.05.001", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.50", "DOI": "10.1210/me.2002-0253", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.51", "DOI": "10.1126/science.1073734", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.52", "DOI": "10.1128/MCB.22.16.5698-5707.2002", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.53", "DOI": "10.1038/367480a0", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.54", "DOI": "10.1083/jcb.200503106", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.55", "DOI": "10.1074/jbc.M200545200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.56", "DOI": "10.1016/S1535-6108(03)00107-7", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.57", "DOI": "10.1172/JCI200215529", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.58", "DOI": "10.1126/science.1075994", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.59", "DOI": "10.1210/en.139.4.2111", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.60", "DOI": "10.1042/BJ20040704", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.61", "DOI": "10.1200/JCO.2003.02.083", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.62", "DOI": "10.1074/jbc.M204751200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.63", "DOI": "10.1073/pnas.91.3.839", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.64", "DOI": "10.1073/pnas.92.2.492", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.65", "DOI": "10.1074/jbc.M306219200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.66", "DOI": "10.1074/jbc.M206727200", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.67", "DOI": "10.1002/jcb.10653", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.68", "DOI": "10.1158/0008-5472.CAN-03-3486", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.69", "volume": "1", "first-page": "385", "year": "2003", "journal-title": "Mol. Cancer Res."}, {"key": "2017062701085530000_6.2.252.70", "DOI": "10.1158/0008-5472.CAN-04-2837", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.71", "volume": "62", "first-page": "5632", "year": "2002", "journal-title": "Cancer Res."}, {"key": "2017062701085530000_6.2.252.72", "DOI": "10.1016/S0303-7207(02)00263-0", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.73", "DOI": "10.1002/pros.20048", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.74", "DOI": "10.1091/mbc.E04-11-1014", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.75", "DOI": "10.1038/nature02542", "doi-asserted-by": "publisher"}, {"key": "2017062701085530000_6.2.252.76", "DOI": "10.1083/jcb.140.6.1383", "doi-asserted-by": "publisher"}], "container-title": ["Molecular & Cellular Proteomics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1074/mcp.M600169-MCP200", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 27]], "date-time": "2017-06-27T08:30:26Z", "timestamp": 1498552226000}, "score": 25.47902, "subtitle": ["Cytoskeleton and Endosomes Modulate Androgen Receptor Signaling in Prostate Cancer Cells"], "issued": {"date-parts": [[2006, 10, 18]]}, "references-count": 76, "journal-issue": {"published-online": {"date-parts": [[2007, 2, 8]]}, "published-print": {"date-parts": [[2007, 2]]}, "issue": "2"}, "alternative-id": ["10.1074/mcp.M600169-MCP200"], "URL": "http://dx.doi.org/10.1074/mcp.m600169-mcp200", "relation": {"cites": []}, "ISSN": ["1535-9476", "1535-9484"], "issn-type": [{"value": "1535-9476", "type": "print"}, {"value": "1535-9484", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T01:43:57Z", "timestamp": 1575510237584}, "reference-count": 49, "publisher": "Wiley", "issue": "15", "license": [{"URL": "http://onlinelibrary.wiley.com/termsAndConditions#am", "start": {"date-parts": [[2020, 9, 8]], "date-time": "2020-09-08T00:00:00Z", "timestamp": 1599523200000}, "delay-in-days": 365, "content-version": "am"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2019, 9, 9]], "date-time": "2019-09-09T00:00:00Z", "timestamp": 1567987200000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2019, 9, 9]], "date-time": "2019-09-09T00:00:00Z", "timestamp": 1567987200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000005", "name": "U.S. Department of Defense", "doi-asserted-by": "publisher", "award": ["DOD Prostate CDMRP Clinical Trials Consortium Grant"]}], "content-domain": {"domain": ["onlinelibrary.wiley.com"], "crossmark-restriction": true}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2019, 11]]}, "DOI": "10.1002/pros.23899", "type": "journal-article", "created": {"date-parts": [[2019, 9, 9]], "date-time": "2019-09-09T10:06:46Z", "timestamp": 1568023606000}, "page": "1752-1761", "update-policy": "http://dx.doi.org/10.1002/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration\u2010resistant prostate cancer"], "prefix": "10.1002", "volume": "79", "author": [{"given": "Daniel J.", "family": "George", "sequence": "first", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Division of Medical Oncology, Department of MedicineDuke University Durham North Carolina"}]}, {"given": "Susan", "family": "Halabi", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Department of BiostatisticsDuke University Durham North Carolina"}]}, {"given": "Patrick", "family": "Healy", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Department of BiostatisticsDuke University Durham North Carolina"}]}, {"given": "Ian", "family": "Barak", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Department of BiostatisticsDuke University Durham North Carolina"}]}, {"given": "Carolyn", "family": "Winters", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}]}, {"ORCID": "http://orcid.org/0000-0001-8634-4952", "authenticated-orcid": false, "given": "Monika", "family": "Anand", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}]}, {"given": "Rhonda", "family": "Wilder", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}]}, {"given": "Melissa", "family": "Klein", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}]}, {"given": "Elia", "family": "Martinez", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Section of Hematology/OncologyUniversity of Chicago Chicago Illinois"}]}, {"given": "Andrew B.", "family": "Nixon", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Division of Medical Oncology, Department of MedicineDuke University Durham North Carolina"}]}, {"given": "Michael R.", "family": "Harrison", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Division of Medical Oncology, Department of MedicineDuke University Durham North Carolina"}]}, {"given": "Russell", "family": "Szmulewitz", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Section of Hematology/OncologyUniversity of Chicago Chicago Illinois"}]}, {"given": "Andrew J.", "family": "Armstrong", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Institute Center for Prostate and Urologic CancersDuke University Durham North Carolina"}, {"name": "Division of Medical Oncology, Department of MedicineDuke University Durham North Carolina"}]}], "member": "311", "published-online": {"date-parts": [[2019, 9, 9]]}, "reference": [{"key": "e_1_2_6_1_2_1", "DOI": "10.1056/NEJMoa1405095", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_3_1", "DOI": "10.1016/S1470-2045(14)71205-7", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_4_1", "DOI": "10.1056/NEJMoa041318", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_5_1", "DOI": "10.1056/NEJMoa040720", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_6_1", "DOI": "10.1093/annonc/mdn288", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_7_1", "DOI": "10.1158/1078-0432.CCR-07-1036", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_8_1", "DOI": "10.1016/j.ejca.2009.11.007", "doi-asserted-by": "publisher"}, {"issue": "6", "key": "e_1_2_6_1_9_1", "first-page": "2533", "article-title": "Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone\u2010refractory prostate cancer patients: a cancer and leukemia group B study", "volume": "61", "author": "Bok RA", "year": "2001", "journal-title": "Cancer Res"}, {"key": "e_1_2_6_1_10_1", "DOI": "10.1016/S0090-4295(99)00167-3", "doi-asserted-by": "publisher"}, {"issue": "7", "key": "e_1_2_6_1_11_1", "first-page": "1932", "article-title": "Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone\u2010refractory prostate cancer treated on cancer and leukemia group B 9480", "volume": "7", "author": "George DJ", "year": "2001", "journal-title": "Clinical Can Res"}, {"key": "e_1_2_6_1_12_1", "DOI": "10.1034/j.1600-0463.2002.100209.x", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "e_1_2_6_1_13_1", "first-page": "3791", "article-title": "Independent prognostic importance of microvessel density in clinically localized prostate cancer", "volume": "20", "author": "Halvorsen OJ", "year": "2000", "journal-title": "Anticancer Res"}, {"issue": "1", "key": "e_1_2_6_1_14_1", "first-page": "81", "article-title": "Independent association of angiogenesis index with outcome in prostate cancer", "volume": "7", "author": "Mehta R", "year": "2001", "journal-title": "Clinical Cancer Res"}, {"key": "e_1_2_6_1_15_1", "DOI": "10.1016/S0090-4295(99)00598-1", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_16_1", "DOI": "10.1038/bjc.1998.605", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_17_1", "DOI": "10.1056/NEJMoa032691", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_18_1", "DOI": "10.1056/NEJMoa065044", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_19_1", "DOI": "10.1200/JCO.2009.23.9764", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_20_1", "DOI": "10.1016/S0140-6736(12)60651-5", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_21_1", "DOI": "10.1200/JCO.2012.48.5268", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_22_1", "DOI": "10.1016/S1470-2045(13)70184-0", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_23_1", "DOI": "10.1200/JCO.2011.39.4767", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_24_1", "DOI": "10.1056/NEJMoa1303989", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_25_1", "DOI": "10.1093/annonc/mdr349", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_26_1", "DOI": "10.1200/JCO.2007.12.4487", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_27_1", "DOI": "10.1016/j.ejca.2008.10.026", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_28_1", "DOI": "10.1158/1078-0432.CCR-08-2740", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_29_1", "DOI": "10.1002/cam4.806", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_30_1", "DOI": "10.1158/1535-7163.MCT-17-0916", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_31_1", "DOI": "10.1002/cam4.71", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_32_1", "DOI": "10.1200/JCO.2013.52.3696", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_33_1", "DOI": "10.1016/j.ejca.2009.11.007", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_34_1", "DOI": "10.1200/JCO.2016.66.9697", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_35_1", "DOI": "10.1016/j.eururo.2013.09.024", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "e_1_2_6_1_36_1", "first-page": "2289", "article-title": "Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta\u2010analysis", "volume": "8", "author": "Liu ZQ", "year": "2015", "journal-title": "Int J Clin Exp Med"}, {"key": "e_1_2_6_1_37_1", "DOI": "10.1002/pros.23048", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_38_1", "DOI": "10.1002/pros.22506", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "e_1_2_6_1_39_1", "first-page": "2065", "article-title": "VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer", "volume": "33", "author": "Talagas M", "year": "2013", "journal-title": "Anticancer Res"}, {"key": "e_1_2_6_1_40_1", "DOI": "10.7314/APJCP.2012.13.11.5665", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_41_1", "DOI": "10.1002/pros.22596", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "e_1_2_6_1_42_1", "first-page": "99", "article-title": "VEGF is associated with the poor survival of patients with prostate cancer: a meta\u2010analysis", "volume": "2", "author": "Zhan P", "year": "2013", "journal-title": "Transl Androl Urol"}, {"key": "e_1_2_6_1_43_1", "DOI": "10.7150/thno.16752", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_44_1", "DOI": "10.1158/1078-0432.CCR-15-1181", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_45_1", "DOI": "10.1007/s12253-013-9648-7", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_46_1", "DOI": "10.1016/j.ccr.2011.04.008", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_47_1", "DOI": "10.1371/journal.pone.0155950", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_48_1", "DOI": "10.1200/JCO.18.01731", "doi-asserted-by": "publisher"}, {"key": "e_1_2_6_1_49_1", "DOI": "10.1200/JCO.2015.65.7270", "doi-asserted-by": "publisher"}, {"issue": "7", "key": "e_1_2_6_1_50_1", "first-page": "1932", "article-title": "Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone\u2010refractory prostate cancer treated on cancer and leukemia group B 9480", "volume": "7", "author": "George DJ", "year": "2001", "journal-title": "ClinCancer Res."}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23899", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pros.23899", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23899", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 24]], "date-time": "2019-09-24T14:49:07Z", "timestamp": 1569336547000}, "score": 24.89806, "issued": {"date-parts": [[2019, 9, 9]]}, "references-count": 49, "journal-issue": {"published-online": {"date-parts": [[2019, 9, 10]]}, "published-print": {"date-parts": [[2019, 11]]}, "issue": "15"}, "alternative-id": ["10.1002/pros.23899"], "URL": "http://dx.doi.org/10.1002/pros.23899", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137", "1097-0045"], "issn-type": [{"value": "0270-4137", "type": "print"}, {"value": "1097-0045", "type": "electronic"}], "subject": ["Urology", "Oncology"], "assertion": [{"value": "2019-05-14", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2019-08-05", "order": 1, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2019-09-09", "order": 2, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:52:29Z", "timestamp": 1574419949777}, "publisher-location": "Berlin, Heidelberg", "reference-count": 31, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642114946", "type": "print"}, {"value": "9783642114953", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012]]}, "DOI": "10.1007/978-3-642-11495-3_10", "type": "book-chapter", "created": {"date-parts": [[2011, 11, 17]], "date-time": "2011-11-17T15:43:18Z", "timestamp": 1321544598000}, "page": "119-132", "source": "Crossref", "is-referenced-by-count": 1, "title": ["High-Dose-Rate Brachytherapy for the Treatment of Low-, Intermediate-, and High-Risk Prostate Cancer"], "prefix": "10.1007", "author": [{"given": "Mackenzie", "family": "McGee", "sequence": "first", "affiliation": []}, {"given": "Mihai", "family": "Ghilezan", "sequence": "additional", "affiliation": []}, {"given": "Alvaro", "family": "Martinez", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 10, 24]]}, "reference": [{"key": "10_CR1_10", "doi-asserted-by": "publisher", "first-page": "1877", "DOI": "10.1002/(SICI)1097-0142(19991101)86:9<1877::AID-CNCR32>3.0.CO;2-5", "volume": "86", "author": "CJ Mettlin", "year": "1999", "unstructured": "Mettlin CJ, Murphy GP, McDonald CJ et al (1999) The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer 86:1877\u20131882", "journal-title": "Cancer"}, {"key": "10_CR2_10", "doi-asserted-by": "publisher", "first-page": "1987", "DOI": "10.1002/cncr.11774", "volume": "98", "author": "WR Lee", "year": "2003", "unstructured": "Lee WR, Moughan J, Owen JB et al (2003) The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Cancer 98:1987\u20131994", "journal-title": "Cancer"}, {"key": "10_CR3_10", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.6004/jnccn.2010.0012", "volume": "8", "author": "J Mohler", "year": "2010", "unstructured": "Mohler J, Bahnson RR, Boston B et al (2010) NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 8:162\u2013200", "journal-title": "J Natl Compr Canc Netw"}, {"key": "10_CR4_10", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z", "volume": "88", "author": "AA Martinez", "year": "2000", "unstructured": "Martinez AA, Gonzalez JA, Chung AK et al (2000) A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution. Cancer 88:425\u2013432", "journal-title": "Cancer"}, {"key": "10_CR5_10", "first-page": "78", "volume": "3", "author": "P Kupelian", "year": "1997", "unstructured": "Kupelian P, Katcher J, Levin H et al (1997) External beam radiotherapy versus radical prostatectomy for clinical stage T1\u20132 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am 3:78\u201387", "journal-title": "Cancer J Sci Am"}, {"key": "10_CR6_10", "doi-asserted-by": "publisher", "first-page": "839", "DOI": "10.1016/S0360-3016(99)00499-X", "volume": "46", "author": "JC Blasko", "year": "2000", "unstructured": "Blasko JC, Grimm PD, Sylvester JE et al (2000) Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46:839\u2013850", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR7_10", "doi-asserted-by": "publisher", "first-page": "969", "DOI": "10.1001/jama.280.11.969", "volume": "280", "author": "AV D\u2019Amico", "year": "1998", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969\u2013974", "journal-title": "JAMA"}, {"key": "10_CR8_10", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1016/j.ijrobp.2007.10.019", "volume": "71", "author": "TN Eade", "year": "2008", "unstructured": "Eade TN, Horwitz EM, Ruth K et al (2008) A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125) I permanent implant. Int J Radiat Oncol Biol Phys 71:338\u2013345", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR9_10", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1016/S0360-3016(03)00784-3", "volume": "58", "author": "PA Kupelian", "year": "2004", "unstructured": "Kupelian PA, Potters L, Khuntia D et al (2004) Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy \u2009> \u2009or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58:25\u201333", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR10_10", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/S0360-3016(98)00006-6", "volume": "41", "author": "RG Stock", "year": "1998", "unstructured": "Stock RG, Stone NN, Tabert A et al (1998) A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41:101\u2013108", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR11_10", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1097/00130404-200201000-00012", "volume": "8", "author": "K Wallner", "year": "2002", "unstructured": "Wallner K, Merrick G, True L et al (2002) I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial. Cancer J 8:67\u201373", "journal-title": "Cancer J"}, {"key": "10_CR12_10", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1016/S0167-8140(00)00291-7", "volume": "57", "author": "DJ Demanes", "year": "2000", "unstructured": "Demanes DJ, Rodriguez RR, Altieri GA (2000) High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method. Radiother Oncol 57:289\u2013296", "journal-title": "Radiother Oncol"}, {"key": "10_CR13_10", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1016/S0360-3016(00)01463-2", "volume": "49", "author": "AA Martinez", "year": "2001", "unstructured": "Martinez AA, Pataki I, Edmundson G et al (2001) Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys 49:61\u201369", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR14_10", "doi-asserted-by": "publisher", "first-page": "675", "DOI": "10.1016/S0360-3016(00)00687-8", "volume": "48", "author": "Y Yoshioka", "year": "2000", "unstructured": "Yoshioka Y, Nose T, Yoshida K et al (2000) High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48:675\u2013681", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR15_10", "doi-asserted-by": "publisher", "first-page": "1098", "DOI": "10.1097/01.ju.0000113299.34404.22", "volume": "171", "author": "IS Grills", "year": "2004", "unstructured": "Grills IS, Martinez AA, Hollander M et al (2004) High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171:1098\u20131104", "journal-title": "J Urol"}, {"key": "10_CR16_10", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1097/COC.0b013e3181b9cd2f", "volume": "33", "author": "AA Martinez", "year": "2010", "unstructured": "Martinez AA, Demanes J, Vargas C et al (2010) High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer. Am J Clin Oncol 33:481\u2013488", "journal-title": "Am J Clin Oncol"}, {"key": "10_CR17_10", "doi-asserted-by": "publisher", "first-page": "1460", "DOI": "10.1016/S0022-5347(01)64243-5", "volume": "158", "author": "MG Oefelein", "year": "1997", "unstructured": "Oefelein MG, Smith ND, Grayhack JT et al (1997) Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol 158:1460\u20131465", "journal-title": "J Urol"}, {"key": "10_CR18_10", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1016/0360-3016(87)90063-0", "volume": "13", "author": "GE Hanks", "year": "1987", "unstructured": "Hanks GE, Diamond JJ, Krall JM et al (1987) A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys 13:499\u2013505", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR19_10", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1200/JCO.1997.15.3.1013", "volume": "15", "author": "MV Pilepich", "year": "1997", "unstructured": "Pilepich MV, Caplan R, Byhardt RW et al (1997) Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85\u201331. J Clin Oncol 15:1013\u20131021", "journal-title": "J Clin Oncol"}, {"key": "10_CR20_10", "doi-asserted-by": "publisher", "first-page": "1066", "DOI": "10.1016/S1470-2045(10)70223-0", "volume": "11", "author": "M Bolla", "year": "2010", "unstructured": "Bolla M, Van Tienhoven G, Warde P et al (2010) External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol 11:1066\u20131073", "journal-title": "Lancet Oncol"}, {"key": "10_CR21_10", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1016/0360-3016(96)00020-X", "volume": "35", "author": "JD Forman", "year": "1996", "unstructured": "Forman JD, Duclos M, Sharma R et al (1996) Conformal mixed neutron and photon irradiation in localized and locally advanced prostate cancer: preliminary estimates of the therapeutic ratio. Int J Radiat Oncol Biol Phys 35:259\u2013266", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR22_10", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1016/0360-3016(95)00063-5", "volume": "32", "author": "WU Shipley", "year": "1995", "unstructured": "Shipley WU, Verhey LJ, Munzenrider JE et al (1995) Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32:3\u201312", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR23_10", "doi-asserted-by": "publisher", "first-page": "491", "DOI": "10.1016/S0360-3016(98)00091-1", "volume": "41", "author": "MJ Zelefsky", "year": "1998", "unstructured": "Zelefsky MJ, Leibel SA, Gaudin PB et al (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491\u2013500", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR24_10", "doi-asserted-by": "publisher", "first-page": "861", "DOI": "10.1016/0360-3016(96)00207-6", "volume": "35", "author": "GE Hanks", "year": "1996", "unstructured": "Hanks GE, Lee WR, Hanlon AL et al (1996) Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen \u2009> \u2009or \u2009= \u200910 NG/ML. Int J Radiat Oncol Biol Phys 35:861\u2013868", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR25_10", "doi-asserted-by": "publisher", "first-page": "974", "DOI": "10.1097/01.ju.0000052720.62999.a9", "volume": "169", "author": "A Martinez", "year": "2003", "unstructured": "Martinez A, Gonzalez J, Spencer W et al (2003) Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 169:974\u2013979", "journal-title": "J Urol"}, {"key": "10_CR26_10", "doi-asserted-by": "publisher", "first-page": "1048", "DOI": "10.1016/j.ijrobp.2003.08.003", "volume": "58", "author": "RM Galalae", "year": "2004", "unstructured": "Galalae RM, Martinez A, Mate T et al (2004) Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58:1048\u20131055", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR27_10", "doi-asserted-by": "publisher", "first-page": "1215", "DOI": "10.1016/0360-3016(93)90546-8", "volume": "27", "author": "GK Edmundson", "year": "1993", "unstructured": "Edmundson GK, Rizzo NR, Teahan M et al (1993) Concurrent treatment planning for outpatient high dose rate prostate template implants. Int J Radiat Oncol Biol Phys 27:1215\u20131223", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR28_10", "doi-asserted-by": "publisher", "first-page": "1257", "DOI": "10.1016/0360-3016(95)00276-6", "volume": "33", "author": "GK Edmundson", "year": "1995", "unstructured": "Edmundson GK, Yan D, Martinez AA (1995) Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys 33:1257\u20131263", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR29_10", "doi-asserted-by": "publisher", "first-page": "1322", "DOI": "10.1016/j.ijrobp.2004.12.053", "volume": "62", "author": "AA Martinez", "year": "2005", "unstructured": "Martinez AA, Demanes DJ, Galalae R et al (2005) Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 62:1322\u20131331", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10_CR30_10", "doi-asserted-by": "publisher", "first-page": "1631", "DOI": "10.1111/j.1464-410X.2009.08661.x", "volume": "104", "author": "RG Stock", "year": "2009", "unstructured": "Stock RG, Cesaretti JA, Hall SJ et al (2009) Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy. BJU Int 104:1631\u20131636", "journal-title": "BJU Int"}, {"key": "10_CR31_10", "doi-asserted-by": "publisher", "first-page": "1265", "DOI": "10.1002/cncr.22116", "volume": "107", "author": "PJ Bastian", "year": "2006", "unstructured": "Bastian PJ, Gonzalgo ML, Aronson WJ et al (2006) Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer 107:1265\u20131272", "journal-title": "Cancer"}], "container-title": ["Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-11495-3_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T18:35:12Z", "timestamp": 1555612512000}, "score": 24.337572, "issued": {"date-parts": [[2011, 10, 24]]}, "ISBN": ["9783642114946", "9783642114953"], "references-count": 31, "URL": "http://dx.doi.org/10.1007/978-3-642-11495-3_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:20:59Z", "timestamp": 1574742059392}, "reference-count": 30, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 3, 1]], "date-time": "2016-03-01T00:00:00Z", "timestamp": 1456790400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2016, 3]]}, "DOI": "10.1016/j.juro.2015.10.172", "type": "journal-article", "created": {"date-parts": [[2015, 11, 7]], "date-time": "2015-11-07T01:58:17Z", "timestamp": 1446861497000}, "page": "619-626", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile"], "prefix": "10.1097", "volume": "195", "author": [{"given": "Javier C.", "family": "Angulo", "sequence": "first", "affiliation": [{"name": "Servicio de Urolog\u00eda, Hospital Universitario de Getafe, Departamento Cl\u00ednico, Facultad de Ciencias Biom\u00e9dicas, Universidad Europea de Madrid, Laureate Universities, Getafe, Spain"}]}, {"given": "Guillermo", "family": "Andr\u00e9s", "sequence": "additional", "affiliation": [{"name": "Servicio de Urolog\u00eda, Hospital Universitario de Getafe, Departamento Cl\u00ednico, Facultad de Ciencias Biom\u00e9dicas, Universidad Europea de Madrid, Laureate Universities, Getafe, Spain"}]}, {"given": "Nadia", "family": "Ashour", "sequence": "additional", "affiliation": [{"name": "Departamento de Biolog\u00eda de Sistemas, Unidad Docente de Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad de Alcal\u00e1, Alcal\u00e1 de Henares, Bilbao, Spain"}]}, {"given": "Manuel", "family": "S\u00e1nchez-Chapado", "sequence": "additional", "affiliation": [{"name": "Servicio de Urolog\u00eda, Hospital Universitario Pr\u00edncipe de Asturias, Universidad de Alcal\u00e1, Alcal\u00e1 de Henares, Bilbao, Spain"}]}, {"given": "Jose I.", "family": "L\u00f3pez", "sequence": "additional", "affiliation": [{"name": "Servicio de Anatom\u00eda Patol\u00f3gica, Hospital Universitario de Cruces, Instituto BioCruces, Universidad del Pa\u00eds Vasco, Bilbao, Spain"}]}, {"given": "Santiago", "family": "Ropero", "sequence": "additional", "affiliation": [{"name": "Departamento de Biolog\u00eda de Sistemas, Unidad Docente de Bioqu\u00edmica y Biolog\u00eda Molecular, Universidad de Alcal\u00e1, Alcal\u00e1 de Henares, Bilbao, Spain"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S002253471505199X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S002253471505199X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T13:42:33Z", "timestamp": 1560778953000}, "score": 23.943775, "issued": {"date-parts": [[2016, 3]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2016, 3]]}, "issue": "3"}, "alternative-id": ["10.1016/j.juro.2015.10.172"], "URL": "http://dx.doi.org/10.1016/j.juro.2015.10.172", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T02:32:57Z", "timestamp": 1575253977649}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "6_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2018, 2, 20]]}, "abstract": "<jats:p> 230 </jats:p><jats:p> Background: Retrospective database studies have suggested that statins may have a positive impact on some mCRPC pts treated with prednisone (P)/abiraterone (AA) Methods: We conducted a post-hoc analysis of individual pt data of mCRPC pts treated with AA and/or P on randomized phase III clinical trials COU -AA-301 and COU-AA-302 to analyze the impact of statins on overall survival (OS). Statistical analyses were performed using the Kaplan Meier method and Cox regression adjusted for known prognostic factors. This study, was carried out under YODA Project #2016-1136 Results: 458 (41%) prechemotherapy pts and 348 (29%) postchemotherapy pts were statins users (Table). Improved OS was observed for mCPRC pts who were statins users in the postdocetaxel setting [HR: 0.82 (95% CI: 0.71 to 0.94); p = 0.006], and there was a trend towards a prolonged OS in the predocetaxel setting [HR: 0.89 (95% CI: 0.77 to 1.03); p = 0.13] adjusted by interventional treatment (AA and/or P). In the predocetaxel setting there were no significant differences in OS between the groups AA/P/non-statin users and placebo/P/statin users (p=0.3). In the multivariate analysis, patients randomized to AA/P who were statins users and presenting ECOG &lt;2 had superior OS in the postdocetaxel setting. Similarly, age, ECOG and statin use were the strongest prognostic factors in the predocetaxel setting. Conclusions: In a post-hoc analysis of two prospective randomized clinical trials statin use was associated with superior OS in mCPRC pts treated with P or AA/P. Further studies are needed to confirm these results and guide use of statins as adjunct to P and A. [Table: see text] </jats:p>", "DOI": "10.1200/jco.2018.36.6_suppl.230", "type": "journal-article", "created": {"date-parts": [[2018, 2, 26]], "date-time": "2018-02-26T21:14:10Z", "timestamp": 1519679650000}, "page": "230-230", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Impact of statins on outcomes in patients (pts) with metastatic castration resistant prostate cancer (mCRPC): Post-hoc analysis of data from COU-AA-301 and COU-AA-302 trials."], "prefix": "10.1200", "volume": "36", "author": [{"given": "Guillermo", "family": "de Velasco", "sequence": "first", "affiliation": [{"name": "Hospital 12 de Octubre, Madrid, Spain;"}]}, {"given": "David", "family": "Lora", "sequence": "additional", "affiliation": [{"name": "Hospital 12 de Octubre, Madrid, Spain;"}]}, {"given": "David", "family": "Lorente", "sequence": "additional", "affiliation": [{"name": "Servicio Oncologia Medica Hospital Universitario La Fe, Valencia, Spain;"}]}, {"given": "Toni K.", "family": "Choueiri", "sequence": "additional", "affiliation": [{"name": "Dana-Farber Cancer Institute/ Brigham and Women\u2019s Hospital/ Harvard Medical School, Boston, MA;"}]}, {"given": "Christopher", "family": "Sweeney", "sequence": "additional", "affiliation": [{"name": "Dana-Farber Cancer Institute, Boston, MA;"}]}, {"given": "Daniel E.", "family": "Castellano", "sequence": "additional", "affiliation": [{"name": "Hospital 12 de Octubre, Madrid, Spain;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.36.6_suppl.230", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:14:06Z", "timestamp": 1574889246000}, "score": 23.943775, "issued": {"date-parts": [[2018, 2, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2018, 2, 20]]}, "issue": "6_suppl"}, "alternative-id": ["10.1200/JCO.2018.36.6_suppl.230"], "URL": "http://dx.doi.org/10.1200/jco.2018.36.6_suppl.230", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T17:18:47Z", "timestamp": 1574702327157}, "reference-count": 49, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 12, 1]], "date-time": "2016-12-01T00:00:00Z", "timestamp": 1480550400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2017, 10, 10]], "date-time": "2017-10-10T00:00:00Z", "timestamp": 1507593600000}, "delay-in-days": 313, "content-version": "am"}], "funder": [{"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "publisher", "award": ["CA88184"]}, {"DOI": "10.13039/100000005", "name": "U.S. Department of Defense", "doi-asserted-by": "publisher", "award": ["PC141559", "PC121645"]}, {"DOI": "10.13039/100006518", "name": "University of Nebraska Medical Center", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/501100004663", "name": "MOST", "doi-asserted-by": "publisher", "award": ["104-2113-M-037-003"]}, {"DOI": "10.13039/100007844", "name": "NSYSUKMU", "doi-asserted-by": "publisher", "award": ["103-I008-1"]}, {"name": "Graduate Studies Fellowship", "award": []}, {"name": "KMU", "award": ["TP104B04"]}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Cancer Letters"], "published-print": {"date-parts": [[2016, 12]]}, "DOI": "10.1016/j.canlet.2016.09.008", "type": "journal-article", "created": {"date-parts": [[2016, 9, 29]], "date-time": "2016-09-29T05:44:36Z", "timestamp": 1475127876000}, "page": "94-105", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Statin derivatives as therapeutic agents for castration-resistant prostate cancer"], "prefix": "10.1016", "volume": "383", "author": [{"given": "Matthew A.", "family": "Ingersoll", "sequence": "first", "affiliation": []}, {"given": "Dannah R.", "family": "Miller", "sequence": "additional", "affiliation": []}, {"given": "October", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "C. Brent", "family": "Wakefield", "sequence": "additional", "affiliation": []}, {"given": "Kuan-Chan", "family": "Hsieh", "sequence": "additional", "affiliation": []}, {"given": "M. Vijaya", "family": "Simha", "sequence": "additional", "affiliation": []}, {"given": "Chai-Lin", "family": "Kao", "sequence": "additional", "affiliation": []}, {"given": "Hui-Ting", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "Surinder K.", "family": "Batra", "sequence": "additional", "affiliation": []}, {"given": "Ming-Fong", "family": "Lin", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S030438351630550X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S030438351630550X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T22:38:50Z", "timestamp": 1565390330000}, "score": 23.545362, "issued": {"date-parts": [[2016, 12]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2016, 12]]}, "issue": "1"}, "alternative-id": ["S030438351630550X"], "URL": "http://dx.doi.org/10.1016/j.canlet.2016.09.008", "ISSN": ["0304-3835"], "issn-type": [{"value": "0304-3835", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Statin derivatives as therapeutic agents for castration-resistant prostate cancer", "name": "articletitle", "label": "Article Title"}, {"value": "Cancer Letters", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.canlet.2016.09.008", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:36:49Z", "timestamp": 1574419009058}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 10, 1]], "date-time": "2011-10-01T00:00:00Z", "timestamp": 1317427200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Journal of Radiation Oncology*Biology*Physics"], "published-print": {"date-parts": [[2011, 10]]}, "DOI": "10.1016/j.ijrobp.2011.06.1352", "type": "journal-article", "created": {"date-parts": [[2011, 11, 15]], "date-time": "2011-11-15T08:04:29Z", "timestamp": 1321344269000}, "page": "S707", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Radiosensitivity in Prostate Cancer Cell Lines following Combination Treatment with Prostate-specific Dietary Supplements and 5-alpha-reductase Inhibitors"], "prefix": "10.1016", "volume": "81", "author": [{"given": "S.A.", "family": "Krueger", "sequence": "first", "affiliation": []}, {"given": "D.M.", "family": "Schoenherr", "sequence": "additional", "affiliation": []}, {"given": "A.A.", "family": "Martinez", "sequence": "additional", "affiliation": []}, {"given": "G.D.", "family": "Wilson", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Marples", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["International Journal of Radiation Oncology*Biology*Physics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0360301611021730?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0360301611021730?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 28]], "date-time": "2018-11-28T15:24:52Z", "timestamp": 1543418692000}, "score": 23.48919, "issued": {"date-parts": [[2011, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2011, 10]]}, "issue": "2"}, "alternative-id": ["S0360301611021730"], "URL": "http://dx.doi.org/10.1016/j.ijrobp.2011.06.1352", "ISSN": ["0360-3016"], "issn-type": [{"value": "0360-3016", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:08:52Z", "timestamp": 1574806132919}, "reference-count": 8, "publisher": "Informa UK Limited", "issue": "5", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Molecular & Cellular Oncology"], "published-print": {"date-parts": [[2017, 9, 3]]}, "DOI": "10.1080/23723556.2017.1345352", "type": "journal-article", "created": {"date-parts": [[2017, 7, 5]], "date-time": "2017-07-05T20:57:29Z", "timestamp": 1499288249000}, "page": "e1345352", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 0, "title": ["JumonjiC demethylase inhibitors show potential for targeting chemotherapy-resistant lung cancers"], "prefix": "10.1080", "volume": "4", "author": [{"given": "Maithili P.", "family": "Dalvi", "sequence": "first", "affiliation": [{"name": "Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA"}]}, {"given": "Elisabeth D.", "family": "Martinez", "sequence": "additional", "affiliation": [{"name": "Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, and Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA"}]}], "member": "301", "published-online": {"date-parts": [[2017, 7, 5]]}, "reference": [{"key": "cit0001", "DOI": "10.1016/j.jtcvs.2006.10.019", "doi-asserted-by": "publisher"}, {"key": "cit0002", "DOI": "10.1016/j.celrep.2017.04.077", "doi-asserted-by": "publisher"}, {"key": "cit0003", "DOI": "10.1016/j.cell.2010.02.027", "doi-asserted-by": "publisher"}, {"key": "cit0004", "DOI": "10.1016/j.ccr.2013.05.003", "doi-asserted-by": "publisher"}, {"key": "cit0005", "DOI": "10.1016/j.stem.2016.11.003", "doi-asserted-by": "publisher"}, {"key": "cit0006", "DOI": "10.1038/nchembio.2085", "doi-asserted-by": "publisher"}, {"key": "cit0007", "DOI": "10.1038/ncomms3035", "doi-asserted-by": "publisher"}, {"key": "cit0008", "DOI": "10.4155/fmc.15.140", "doi-asserted-by": "publisher"}], "container-title": ["Molecular & Cellular Oncology"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1080/23723556.2017.1345352", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 16]], "date-time": "2017-10-16T17:47:54Z", "timestamp": 1508176074000}, "score": 23.390802, "issued": {"date-parts": [[2017, 7, 5]]}, "references-count": 8, "journal-issue": {"published-online": {"date-parts": [[2017, 9, 18]]}, "published-print": {"date-parts": [[2017, 9, 3]]}, "issue": "5"}, "alternative-id": ["10.1080/23723556.2017.1345352"], "URL": "http://dx.doi.org/10.1080/23723556.2017.1345352", "relation": {"cites": []}, "ISSN": ["2372-3556"], "issn-type": [{"value": "2372-3556", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kmco20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kmco20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}